NICOLAHANANIANICOLA HANANIA29.70990600000000-95.402830000000002039HANANIA, NICOLAAsthma, COPD, bronchodilators, beta-adrenergic agonists, biomarkers, comorbidities, agingNicola (Nick) A. Hanania, MD, MS is Professor of Medicine in the Section of Pulmonary and Critical Care Medicine and Director of the Airways Clinical Research Center at the Baylor College of Medicine in Houston, Texas, USA. He is Chief of the Section of Pulmonary and Critical Care Medicine at Ben Taub Hospital in Houston. He completed his medical training at the University of Jordan followed by residency in internal medicine and a fellowship in pulmonary medicine at the University of Toronto, Canada. He subsequently completed a fellowship in critical care medicine at Baylor College of Medicine, where he later earned a master’s degree in clinical investigation.
Dr. Hanania is a fellow of the Royal College of Physicians and Surgeons of Canada, The American College of Chest Physicians, the American College of Physicians and the European Respiratory Society. As a Fellow of the American College of Chest Physicians, Dr. Hanania has served on the Board of Regents and as Chair of the Clinical Pulmonary, Airways Networks and Council of Networks for this organization. He has been on the Board of Trustees of the Chest Foundation since 2012. In addition, he served as a member of the Health Policy Committee of the American Thoracic Societyand on several guideline and workshop panels including the ACP/ATS/ACCP/ERS Clinical Practice guidelines on COPD and the CTS/ACCP COPD exacerbations guidelines.
Dr. Hanania has received multiple awards including the Master Clinician Award from Baylor College of Medicine and the Distinguished Scholar in Respiratory Health from the American College of Chest Physicians. He is editor-in-chief of Respiratory Medicine and is Associate Editor of Current Opinion in Pulmonary Medicine (Asthma Section) and Lung and member of Editorial Board of CHEST and Journal of COPD.
Dr. Hanania’s research interests focus on the pharmacology and management of asthma and COPD. He has published more than 200 peer-reviewed papers, book chapters, editorials and reviews on these topics. He is actively involved in clinical trials investigating novel treatments. He is Principal Investigator for the American Lung Association Airway Clinical Research Center at Baylor College of Medicine, as well as Principal Investigator or Co-Investigator in several clinical trials in asthma and COPD. He has been invited and has lectured widely at local, regional, national and international meetings.Professorprns:awardConferredByaward conferred byprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provinceAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipvivo:awardOrHonorawards and honorsAward or Honor ReceiptDepartmentDivisionvivo:freetextKeywordkeywordsGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:orcidIdORCID idvivo:overviewoverviewvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 156369225415408Parulekar AD, Diamant Z, Hanania NACurrent opinion in pulmonary medicineAntifungals in severe asthma. Curr Opin Pulm Med. 2015 Jan; 21(1):48-54.Curr Opin Pulm Med2015-01-01T00:00:002015Antifungals in severe asthma.25415409Rogers L, Hanania NACurrent opinion in pulmonary medicineRole of anticholinergics in asthma management: recent evidence and future needs. Curr Opin Pulm Med. 2015 Jan; 21(1):103-8.Curr Opin Pulm Med2015-01-01T00:00:002015Role of anticholinergics in asthma management: recent evidence and future needs.25451347Donohue JF, Hanania NA, Make B, Miles MC, Mahler DA, Curry L, Tosiello R, Wheeler A, Tashkin DPChestOne-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD. Chest. 2014 Dec; 146(6):1531-1542.Chest2014-12-01T00:00:002014One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD.25514500Putcha N, Puhan MA, Drummond MB, Han MK, Regan EA, Hanania NA, Martinez CH, Foreman M, Bhatt SP, Make B, Ramsdell J, DeMeo DL, Barr RG, Rennard SI, Martinez F, Silverman EK, Crapo J, Wise RA, Hansel NNPloS oneA simplified score to quantify comorbidity in COPD. PLoS One. 2014; 9(12):e114438.PLoS One2014-12-16T00:00:002014A simplified score to quantify comorbidity in COPD.Authorship 807964Authorship 818662Authorship 832672Authorship 838241Authorship 841874Authorship 84702Authorship 890361Authorship 898044Authorship 901622Authorship 922379Authorship 927897Authorship 931681Authorship 1026212Authorship 1069758Authorship 1128244Authorship 119781Authorship 12972Authorship 2433224Authorship 1608695Authorship 16094016Authorship 16143316Authorship 1617594Authorship 162068325320966Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, Fiel SB, Foreman MG, Hanania NA, Ireland BK, Marchetti N, Marciniuk DD, Mularski RA, Ornelas J, Road JD, Stickland MKChestExecutive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015 Apr; 147(4):883-893.Chest2015-04-01T00:00:002015Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.25321320Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, Fiel SB, Foreman MG, Hanania NA, Ireland BK, Marchetti N, Marciniuk DD, Mularski RA, Ornelas J, Road JD, Stickland MKChestPrevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015 Apr; 147(4):894-942.Chest2015-04-01T00:00:002015Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.25490706Crim C, Dransfield MT, Bourbeau J, Jones PW, Hanania NA, Mahler DA, Vestbo J, Wachtel A, Martinez FJ, Barnhart F, Lettis S, Calverley PMAnnals of the American Thoracic SocietyPneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD. Ann Am Thorac Soc. 2015 Jan; 12(1):27-34.Ann Am Thorac Soc2015-01-01T00:00:002015Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.25712010Bujarski S, Parulekar AD, Sharafkhaneh A, Hanania NACurrent allergy and asthma reportsThe asthma COPD overlap syndrome (ACOS). Curr Allergy Asthma Rep. 2015 Mar; 15(3):509.Curr Allergy Asthma Rep2015-03-01T00:00:002015The asthma COPD overlap syndrome (ACOS).25820201Chow L, Parulekar AD, Hanania NAJournal of hospital medicineHospital management of acute exacerbations of chronic obstructive pulmonary disease. J Hosp Med. 2015 May; 10(5):328-39.J Hosp Med2015-03-27T00:00:002015Hospital management of acute exacerbations of chronic obstructive pulmonary disease.Authorship 324911Authorship 341623Laboratory MedicinePalliative Care & Rehabilitation MedicineMD AndersonDAVIDHUIDAVID HUI9525HUI, DAVIDAssociate ProfessorFERNANDOMARTINEZFERNANDO MARTINEZ9091MARTINEZ, FERNANDOAssistant ProfessorAuthorship 494834Authorship 589653Authorship 677871Authorship 711031Authorship 723233Authorship 772072Authorship 790915Authorship 820112Authorship 8813017847437Hanania NA, Chapman KR, Kesten SThe American journal of medicineAdverse effects of inhaled corticosteroids. Am J Med. 1995 Feb; 98(2):196-208.Am J Med1995-02-01T00:00:001995Adverse effects of inhaled corticosteroids.7499672Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten SThe Journal of allergy and clinical immunologyDose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 1995 Nov; 96(5 Pt 1):571-9.J Allergy Clin Immunol1995-11-01T00:00:001995Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids.7781347Kesten S, Chew R, Hanania NAChestHealth-care utilization after near-fatal asthma. Chest. 1995 Jun; 107(6):1564-9.Chest1995-06-01T00:00:001995Health-care utilization after near-fatal asthma.8275720Hanania NA, Wittman R, Kesten S, Chapman KRChestMedical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest. 1994 Jan; 105(1):111-6.Chest1994-01-01T00:00:001994Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers.8549178Rebuck DA, Hanania NA, D'Urzo AD, Chapman KRChestThe accuracy of a handheld portable spirometer. Chest. 1996 Jan; 109(1):152-7.Chest1996-01-01T00:00:001996The accuracy of a handheld portable spirometer.9743162Hanania NA, Tarlo SM, Silverman F, Urch B, Senathirajah N, Zamel N, Corey PChestEffect of exposure to low levels of ozone on the response to inhaled allergen in allergic asthmatic patients. Chest. 1998 Sep; 114(3):752-6.Chest1998-09-01T00:00:001998Effect of exposure to low levels of ozone on the response to inhaled allergen in allergic asthmatic patients.9881400Hanania NA, Pope C, Guntupalli KKRespiratory care clinics of North AmericaAcute respiratory distress syndrome. Inhaled nitric oxide. Respir Care Clin N Am. 1998 Dec; 4(4):695-709.Respir Care Clin N Am1998-12-01T00:00:001998Acute respiratory distress syndrome. Inhaled nitric oxide.9891630Zimmerman JL, Hanania NACritical care clinicsVasodilators in mechanical ventilation. Crit Care Clin. 1998 Oct; 14(4):611-27.Crit Care Clin1998-10-01T00:00:001998Vasodilators in mechanical ventilation.1504 TAUB LOOPHouston, 77030TXAuthorship 3004944Authorship 3006511Authorship 3020712Authorship 3027412Authorship 303644125897216Cazzola M, Hanania NA, MacNee W, R?dell K, Hackford C, Tamimi NInternational journal of chronic obstructive pulmonary diseaseA review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges. Int J Chron Obstruct Pulmon Dis. 2015; 10:725-38.Int J Chron Obstruct Pulmon Dis2015-04-07T00:00:002015A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges.26001563Hanania NA, Noonan M, Corren J, Korenblat P, Zheng Y, Fischer SK, Cheu M, Putnam WS, Murray E, Scheerens H, Holweg CT, Maciuca R, Gray S, Doyle R, McClintock D, Olsson J, Matthews JG, Yen KThoraxLebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax. 2015 Aug; 70(8):748-56.Thorax2015-05-22T00:00:002015Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.26540421Douglas IS, Albertson TE, Folan P, Hanania NA, Tashkin DP, Upson DJ, Leone FTAnnals of the American Thoracic SocietyImplications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup. Ann Am Thorac Soc. 2015 Nov; 12(11):1700-10.Ann Am Thorac Soc2015-11-01T00:00:002015Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup.26574722Diamant Z, Hanania NACurrent opinion in pulmonary medicineEditorial: The new look on asthma: linking phenotypes, endotypes and biomarkers to asthma management. Curr Opin Pulm Med. 2016 Jan; 22(1):1-2.Curr Opin Pulm Med2016-01-01T00:00:002016Editorial: The new look on asthma: linking phenotypes, endotypes and biomarkers to asthma management.26574724Parulekar AD, Diamant Z, Hanania NACurrent opinion in pulmonary medicineRole of T2 inflammation biomarkers in severe asthma. Curr Opin Pulm Med. 2016 Jan; 22(1):59-68.Curr Opin Pulm Med2016-01-01T00:00:002016Role of T2 inflammation biomarkers in severe asthma.9891633Jain S, Hanania NA, Guntupalli KKCritical care clinicsVentilation of patients with asthma and obstructive lung disease. Crit Care Clin. 1998 Oct; 14(4):685-705.Crit Care Clin1998-10-01T00:00:001998Ventilation of patients with asthma and obstructive lung disease.9041971Hanania NA, David-Wang A, Kesten S, Chapman KRChestFactors associated with emergency department dependence of patients with asthma. Chest. 1997 Feb; 111(2):290-5.Chest1997-02-01T00:00:001997Factors associated with emergency department dependence of patients with asthma.11999580Nasta SD, Carrum GM, Shahab I, Hanania NA, Udden MMLeukemia & lymphomaRegression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma. 2002 Feb; 43(2):423-6.Leuk Lymphoma2002-02-01T00:00:002002Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy.74Professor10Assistant Professor54Instructor14Associate Professor15978302Make B, Hanania NA, ZuWallack R, Kalberg C, Emmett A, Brown CP, Knobil KClinical therapeuticsThe efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. Clin Ther. 2005 May; 27(5):531-42.Clin Ther2005-05-01T00:00:002005The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.16239101Hanania NA, Ambrosino N, Calverley P, Cazzola M, Donner CF, Make BRespiratory medicineTreatments for COPD. Respir Med. 2005 Dec; 99 Suppl B:S28-40.Respir Med2005-10-18T00:00:002005Treatments for COPD.16451113Hanania NA, Atmar RL, Castro MExpert review of vaccinesInfluenza vaccine in patients with asthma. Expert Rev Vaccines. 2006 Feb; 5(1):111-8.Expert Rev Vaccines2006-02-01T00:00:002006Influenza vaccine in patients with asthma.Authorship 3203276Authorship 3204332Authorship 32074812Authorship 3221389Authorship 3221493Authorship 322369226577335Djukanovic R, Hanania N, Busse W, Price DRespiratory medicineIgE-mediated asthma: New revelations and future insights. Respir Med. 2016 Mar; 112:128-9.Respir Med2015-10-30T00:00:002015IgE-mediated asthma: New revelations and future insights.26712569Checkley W, Foreman MG, Bhatt SP, Dransfield MT, Han M, Hanania NA, Hansel NN, Regan EA, Wise RA, COPDGene Study InvestigatorsRespiratory medicineDifferences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease. Respir Med. 2016 Feb; 111:30-8.Respir Med2015-11-11T00:00:002015Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.26836895Martinez CH, Diaz AA, Parulekar AD, Rennard SI, Kanner RE, Hansel NN, Couper D, Holm KE, Hoth KF, Curtis JL, Martinez FJ, Hanania NA, Regan EA, Paine R, Cigolle CT, Han MK, COPDGene and SPIROMICS InvestigatorsChestAge-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts. Chest. 2016 Apr; 149(4):927-35.Chest2015-12-17T00:00:002015Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts.26836938Yohannes AM, M?llerov? H, Hanania NA, Lavoie K, Tal-Singer R, Vestbo J, Rennard SI, Wouters EFChestLong-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort. Chest. 2016 Apr; 149(4):916-26.Chest2016-01-05T00:00:002016Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort.27215497Buhl R, Korn S, Menzies-Gow A, Aubier M, Chapman KR, Canonica GW, Picado C, Martin N, Escobar RA, Korom S, Hanania NARespiratory medicineAssessing biomarkers in a real-world severe asthma study (ARIETTA). Respir Med. 2016 06; 115:7-12.Respir Med2016-04-14T00:00:002016Assessing biomarkers in a real-world severe asthma study (ARIETTA).27223863Banerji D, Mahler DA, Hanania NAExpert review of respiratory medicineEfficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD. Expert Rev Respir Med. 2016 07; 10(7):767-80.Expert Rev Respir Med2016-05-30T00:00:002016Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD.Authorship 32511918Authorship 32555528Authorship 325692327158740Kim V, Zhao H, Boriek AM, Anzueto A, Soler X, Bhatt SP, Rennard SI, Wise R, Comellas A, Ramsdell JW, Kinney GL, Han MK, Martinez CH, Yen A, Black-Shinn J, Porszasz J, Criner GJ, Hanania NA, Sharafkhaneh A, Crapo JD, Make BJ, Silverman EK, Curtis JL, COPDGene InvestigatorsAnnals of the American Thoracic SocietyPersistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016 07; 13(7):1016-25.Ann Am Thorac Soc2016-07-01T00:00:002016Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease.27532455Sun W, Kechris K, Jacobson S, Drummond MB, Hawkins GA, Yang J, Chen TH, Quibrera PM, Anderson W, Barr RG, Basta PV, Bleecker ER, Beaty T, Casaburi R, Castaldi P, Cho MH, Comellas A, Crapo JD, Criner G, Demeo D, Christenson SA, Couper DJ, Curtis JL, Doerschuk CM, Freeman CM, Gouskova NA, Han MK, Hanania NA, Hansel NN, Hersh CP, Hoffman EA, Kaner RJ, Kanner RE, Kleerup EC, Lutz S, Martinez FJ, Meyers DA, Peters SP, Regan EA, Rennard SI, Scholand MB, Silverman EK, Woodruff PG, O'Neal WK, Bowler RP, SPIROMICS Research Group, COPDGene InvestigatorsPLoS geneticsCommon Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD. PLoS Genet. 2016 Aug; 12(8):e1006011.PLoS Genet2016-08-17T00:00:002016Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.26953219Yohannes AM, Dryden S, Hanania NAChestThe Responsiveness of the Anxiety Inventory for Respiratory Disease Scale Following Pulmonary Rehabilitation. Chest. 2016 07; 150(1):188-95.Chest2016-03-04T00:00:002016The Responsiveness of the Anxiety Inventory for Respiratory Disease Scale Following Pulmonary Rehabilitation.17052901Hanania NA, Moore RH, Zimmerman JL, Miller CT, Bag R, Sharafkhaneh A, Dickey BFRespiratory medicineThe role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma. Respir Med. 2007 May; 101(5):1007-14.Respir Med2006-10-17T00:00:002006The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.15100679Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL, American Lung Association Asthma Clinical Research CentersThe Journal of allergy and clinical immunologyImmune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol. 2004 Apr; 113(4):717-24.J Allergy Clin Immunol2004-04-01T00:00:002004Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.17703976Hanania NA, Singh S, El-Wali R, Flashner M, Franklin AE, Garner WJ, Dickey BF, Parra S, Ruoss S, Shardonofsky F, O'Connor BJ, Page C, Bond RAPulmonary pharmacology & therapeuticsThe safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther. 2008; 21(1):134-41.Pulm Pharmacol Ther2007-07-17T00:00:002007The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.17967288Braman SS, Hanania NAClinics in chest medicineAsthma in older adults. Clin Chest Med. 2007 Dec; 28(4):685-702, v.Clin Chest Med2007-12-01T00:00:002007Asthma in older adults.18042470Hanania NAClinical therapeuticsOptimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes. Clin Ther. 2007 Oct; 29(10):2121-33.Clin Ther2007-10-01T00:00:002007Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.18044091Cazzola M, Hanania NAInternational journal of chronic obstructive pulmonary diseaseThe role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD. Int J Chron Obstruct Pulmon Dis. 2006; 1(4):345-54.Int J Chron Obstruct Pulmon Dis2006-01-01T00:00:002006The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD.18259972Hanrahan JP, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Baumgartner RACOPDEffect of nebulized arformoterol on airway function in COPD: results from two randomized trials. COPD. 2008 Feb; 5(1):25-34.COPD2008-02-01T00:00:002008Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials.18564559Hanania NAManaged care (Langhorne, Pa.)The challenge of differentiating asthma from chronic obstructive pulmonary disease. Manag Care. 2005 Jul; 14(7 Suppl Obstructie Lung):9-15; discussion 24-6.Manag Care2005-07-01T00:00:002005The challenge of differentiating asthma from chronic obstructive pulmonary disease.18582796Cazzola M, Hanania NA, Jones PW, Mahler DA, Make B, Ohar J, Rennard SRespiratory medicineIt's about time--directing our attention toward modifying the course of COPD. Respir Med. 2008 Jun; 102 Suppl 1:S37-48.Respir Med2008-06-01T00:00:002008It's about time--directing our attention toward modifying the course of COPD.15607123Hanania NA, Kalberg C, Yates J, Emmett A, Horstman D, Knobil KPulmonary pharmacology & therapeuticsThe bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD. Pulm Pharmacol Ther. 2005; 18(1):19-22.Pulm Pharmacol Ther2005-01-01T00:00:002005The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD.19124357Donohue JF, Hanania NA, Sciarappa KA, Goodwin E, Grogan DR, Baumgartner RA, Hanrahan JPTherapeutic advances in respiratory diseaseArformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. Ther Adv Respir Dis. 2008 Apr; 2(2):37-48.Ther Adv Respir Dis2008-04-01T00:00:002008Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.15699784Soto FJ, Hanania NACurrent opinion in pulmonary medicineSelective phosphodiesterase-4 inhibitors in chronic obstructive lung disease. Curr Opin Pulm Med. 2005 Mar; 11(2):129-34.Curr Opin Pulm Med2005-03-01T00:00:002005Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease.19171883Nguyen LP, Lin R, Parra S, Omoluabi O, Hanania NA, Tuvim MJ, Knoll BJ, Dickey BF, Bond RAProceedings of the National Academy of Sciences of the United States of AmericaBeta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A. 2009 Feb 17; 106(7):2435-40.Proc Natl Acad Sci U S A2009-01-26T00:00:002009Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model.19537837Hanania NA, Boota A, Kerwin E, Tomlinson L, Denis-Mize KDrugsEfficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. Drugs. 2009 Jun 18; 69(9):1205-16.Drugs2009-06-18T00:00:002009Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.20406080Cazzola M, Hanania NA, Matera MGExpert review of respiratory medicineArformoterol tartrate in the treatment of COPD. Expert Rev Respir Med. 2010 Apr; 4(2):155-62.Expert Rev Respir Med2010-04-01T00:00:002010Arformoterol tartrate in the treatment of COPD.16215354Hanania NA, Belfort MACritical care medicineAcute asthma in pregnancy. Crit Care Med. 2005 Oct; 33(10 Suppl):S319-24.Crit Care Med2005-10-01T00:00:002005Acute asthma in pregnancy.15388199Guy ES, Kirumaki A, Hanania NACritical care clinicsAcute asthma in pregnancy. Crit Care Clin. 2004 Oct; 20(4):731-45, x.Crit Care Clin2004-10-01T00:00:002004Acute asthma in pregnancy.21037960Sharafkhaneh A, Mattewal AS, Abraham VM, Dronavalli G, Hanania NAInternational journal of chronic obstructive pulmonary diseaseBudesonide/formoterol combination in COPD: a US perspective. Int J Chron Obstruct Pulmon Dis. 2010 Oct 05; 5:357-66.Int J Chron Obstruct Pulmon Dis2010-10-05T00:00:002010Budesonide/formoterol combination in COPD: a US perspective.21085552Cully JA, Stanley MA, Deswal A, Hanania NA, Phillips LL, Kunik MEPrimary care companion to the Journal of clinical psychiatryCognitive-behavioral therapy for chronic cardiopulmonary conditions: preliminary outcomes from an open trial. Prim Care Companion J Clin Psychiatry. 2010; 12(4).Prim Care Companion J Clin Psychiatry2010-01-01T00:00:002010Cognitive-behavioral therapy for chronic cardiopulmonary conditions: preliminary outcomes from an open trial.Authorship 328332127616196Hanania NA, Korenblat P, Chapman KR, Bateman ED, Kopecky P, Paggiaro P, Yokoyama A, Olsson J, Gray S, Holweg CT, Eisner M, Asare C, Fischer SK, Peng K, Putnam WS, Matthews JGThe Lancet. Respiratory medicineEfficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2016 10; 4(10):781-796.Lancet Respir Med2016-09-05T00:00:002016Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.21550084Kao CC, Hsu JW, Bandi V, Hanania NA, Kheradmand F, Jahoor FMetabolism: clinical and experimentalResting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease. Metabolism. 2011 Oct; 60(10):1449-55.Metabolism2011-05-06T00:00:002011Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease.21788524Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, Curtis JL, Criner GJ, Kim V, Bowler RP, Hanania NA, Anzueto AR, Make BJ, Hokanson JE, Crapo JD, Silverman EK, Martinez FJ, Washko GR, COPDGene InvestigatorsRadiologyChronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011 Oct; 261(1):274-82.Radiology2011-07-25T00:00:002011Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes.21827298Dalal AA, Shah M, Lunacsek O, Hanania NACOPDClinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD. 2011 Aug; 8(4):293-9.COPD2011-08-09T00:00:002011Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population.21872730Hanania NA, King MJ, Braman SS, Saltoun C, Wise RA, Enright P, Falsey AR, Mathur SK, Ramsdell JW, Rogers L, Stempel DA, Lima JJ, Fish JE, Wilson SR, Boyd C, Patel KV, Irvin CG, Yawn BP, Halm EA, Wasserman SI, Sands MF, Ershler WB, Ledford DK, Asthma in Elderly workshop participantsThe Journal of allergy and clinical immunologyAsthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol. 2011 Sep; 128(3 Suppl):S4-24.J Allergy Clin Immunol2011-09-01T00:00:002011Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop.21896511Hanania NA, Marciniuk DDChestA unified front against COPD: clinical practice guidelines from the American College of Physicians, the American College of Chest Physicians, the American Thoracic Society, and the European Respiratory Society. Chest. 2011 Sep; 140(3):565-566.Chest2011-09-01T00:00:002011A unified front against COPD: clinical practice guidelines from the American College of Physicians, the American College of Chest Physicians, the American Thoracic Society, and the European Respiratory Society.21905763Gross NJ, Hanania NACOPDThe COPD Pipeline XII. COPD. 2011 Oct; 8(5):387-91.COPD2011-09-09T00:00:002011The COPD Pipeline XII.21972384Hanania NA, Celli BR, Donohue JF, Martin UJChestBronchodilator reversibility in COPD. Chest. 2011 Oct; 140(4):1055-1063.Chest2011-10-01T00:00:002011Bronchodilator reversibility in COPD.16980556Moore RH, Millman EE, Godines V, Hanania NA, Tran TM, Peng H, Dickey BF, Knoll BJ, Clark RBAmerican journal of respiratory cell and molecular biologySalmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization. Am J Respir Cell Mol Biol. 2007 Feb; 36(2):254-61.Am J Respir Cell Mol Biol2006-09-15T00:00:002006Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization.23401469Tsai CL, Lee WY, Delclos GL, Hanania NA, Camargo CAJournal of hospital medicineComparative effectiveness of noninvasive ventilation vs invasive mechanical ventilation in chronic obstructive pulmonary disease patients with acute respiratory failure. J Hosp Med. 2013 Apr; 8(4):165-72.J Hosp Med2013-02-11T00:00:002013Comparative effectiveness of noninvasive ventilation vs invasive mechanical ventilation in chronic obstructive pulmonary disease patients with acute respiratory failure.23459224Spencer P, Hanania NAJournal of multidisciplinary healthcareOptimizing safety of COPD treatments: role of the nurse practitioner. J Multidiscip Healthc. 2013; 6:53-63.J Multidiscip Healthc2013-02-21T00:00:002013Optimizing safety of COPD treatments: role of the nurse practitioner.23515335Yohannes AM, Connolly MJ, Hanania NAInternational journal of chronic obstructive pulmonary diseaseTen years of tiotropium: clinical impact and patient perspectives. Int J Chron Obstruct Pulmon Dis. 2013; 8:117-25.Int J Chron Obstruct Pulmon Dis2013-03-15T00:00:002013Ten years of tiotropium: clinical impact and patient perspectives.16635694Nowak R, Emerman C, Hanrahan JP, Parsey MV, Hanania NA, Claus R, Schaefer K, Baumgartner RA, XOPENEX Acute Severe Asthma Study GroupThe American journal of emergency medicineA comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. Am J Emerg Med. 2006 May; 24(3):259-67.Am J Emerg Med2006-05-01T00:00:002006A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.17363238Cazzola M, Donner CF, Hanania NARespiratory medicineOne hundred years of chronic obstructive pulmonary disease (COPD). Respir Med. 2007 Jun; 101(6):1049-65.Respir Med2007-03-23T00:00:002007One hundred years of chronic obstructive pulmonary disease (COPD).17720046Hanania NA, Sharafkhaneh AClinics in chest medicineUpdate on the pharmacologic therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2007 Sep; 28(3):589-607, vi-vii.Clin Chest Med2007-09-01T00:00:002007Update on the pharmacologic therapy for chronic obstructive pulmonary disease.18398119Hanania NAChestTargeting airway inflammation in asthma: current and future therapies. Chest. 2008 Apr; 133(4):989-98.Chest2008-04-01T00:00:002008Targeting airway inflammation in asthma: current and future therapies.Authorship 100043218280761Hanania NAPulmonary pharmacology & therapeuticsThe impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Pulm Pharmacol Ther. 2008; 21(3):540-50.Pulm Pharmacol Ther2008-01-06T00:00:002008The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.18640474Donohue JF, Hanania NA, Ciubotaru RL, Noe L, Pasta DJ, Schaefer K, Claus R, Andrews WT, Roach JClinical therapeuticsComparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study. Clin Ther. 2008; 30 Spec No:989-1002.Clin Ther2008-01-01T00:00:002008Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.18842932Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA, ACCP Workshop Panel on Anxiety and Depression in COPDChestAnxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008 Oct; 134(4 Suppl):43S-56S.Chest2008-10-01T00:00:002008Anxiety and depression in COPD: current understanding, unanswered questions, and research needs.19077698Hanania NACurrent opinion in pulmonary medicineAsthma control: a new perspective on the management of asthma. Curr Opin Pulm Med. 2009 Jan; 15(1):1-3.Curr Opin Pulm Med2009-01-01T00:00:002009Asthma control: a new perspective on the management of asthma.19124352Sharafkhaneh A, Velamuri S, Badmaev V, Lan C, Hanania NTherapeutic advances in respiratory diseaseThe potential role of natural agents in treatment of airway inflammation. Ther Adv Respir Dis. 2007 Dec; 1(2):105-20.Ther Adv Respir Dis2007-12-01T00:00:002007The potential role of natural agents in treatment of airway inflammation.Authorship 6520238Authorship 6522805Authorship 6525884Authorship 6527732Authorship 65280711Authorship 6534424Authorship 653535825695106Putcha N, Han MK, Martinez CH, Foreman MG, Anzueto AR, Casaburi R, Cho MH, Hanania NA, Hersh CP, Kinney GL, Make BJ, Steiner RM, Lutz SM, Thomashow BM, Williams AA, Bhatt SP, Beaty TH, Bowler RP, Ramsdell JW, Curtis JL, Everett D, Hokanson JE, Lynch DA, Sutherland ER, Silverman EK, Crapo JD, Wise RA, Regan EA, Hansel NN, the COPDGene? InvestigatorsChronic obstructive pulmonary diseases (Miami, Fla.)Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. Chronic Obstr Pulm Dis. 2014; 1(1):105-114.Chronic Obstr Pulm Dis2014-01-01T00:00:002014Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.27459257Herscher ML, Wisnivesky JP, Busse PJ, Hanania NA, Sheng T, Wolf MS, Federman ADThe Journal of asthma : official journal of the Association for the Care of AsthmaCharacteristics and outcomes of older adults with long-standing versus late-onset asthma. J Asthma. 2017 04; 54(3):223-229.J Asthma2016-07-26T00:00:002016Characteristics and outcomes of older adults with long-standing versus late-onset asthma.27568229Lambert AA, Putcha N, Drummond MB, Boriek AM, Hanania NA, Kim V, Kinney GL, McDonald MN, Brigham EP, Wise RA, McCormack MC, Hansel NN, COPDGene InvestigatorsChestObesity Is Associated With Increased Morbidity in Moderate to Severe COPD. Chest. 2017 Jan; 151(1):68-77.Chest2016-08-25T00:00:002016Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD.27820746Parulekar AD, Diamant Z, Hanania NACurrent opinion in pulmonary medicineRole of biologics targeting type 2 airway inflammation in asthma: what have we learned so far? Curr Opin Pulm Med. 2017 01; 23(1):3-11.Curr Opin Pulm Med2017-01-01T00:00:002017Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far?27831798Skloot GS, Busse PJ, Braman SS, Kovacs EJ, Dixon AE, Vaz Fragoso CA, Scichilone N, Prakash YS, Pabelick CM, Mathur SK, Hanania NA, Moore WC, Gibson PG, Zieman S, Ragless BB, ATS ad hoc Committee on Asthma in the ElderlyAnnals of the American Thoracic SocietyAn Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly. Ann Am Thorac Soc. 2016 11; 13(11):2064-2077.Ann Am Thorac Soc2016-11-01T00:00:002016An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly.28017627Medrek SK, Kao CC, Yang DH, Hanania NA, Parulekar ADThe journal of allergy and clinical immunology. In practiceFungal Sensitization Is Associated with Increased Risk of Life-Threatening Asthma. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1025-1031.e2.J Allergy Clin Immunol Pract2016-12-22T00:00:002016Fungal Sensitization Is Associated with Increased Risk of Life-Threatening Asthma.28036144Robinson D, Humbert M, Buhl R, Cruz AA, Inoue H, Korom S, Hanania NA, Nair PClinical and experimental allergy : journal of the British Society for Allergy and Clinical ImmunologyRevisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017 Feb; 47(2):161-175.Clin Exp Allergy2017-02-01T00:00:002017Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.Authorship 654703719844181King MJ, Hanania NACurrent opinion in pulmonary medicineAsthma in the elderly: current knowledge and future directions. Curr Opin Pulm Med. 2010 Jan; 16(1):55-9.Curr Opin Pulm Med2010-01-01T00:00:002010Asthma in the elderly: current knowledge and future directions.28128966Sapir T, Moreo KF, Greene LS, Simone LC, Carter JD, Mateka JJL, Hanania NAAnnals of the American Thoracic SocietyAssessing Patient and Provider Perceptions of Factors Associated with Patient Engagement in Asthma Care. Ann Am Thorac Soc. 2017 May; 14(5):659-666.Ann Am Thorac Soc2017-05-01T00:00:002017Assessing Patient and Provider Perceptions of Factors Associated with Patient Engagement in Asthma Care.19934352Sharma G, Hanania NA, Shim YMProceedings of the American Thoracic SocietyThe aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009 Dec 01; 6(7):573-80.Proc Am Thorac Soc2009-12-01T00:00:002009The aging immune system and its relationship to the development of chronic obstructive pulmonary disease.20399707Dickey BF, Walker JK, Hanania NA, Bond RACurrent opinion in pharmacologybeta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol. 2010 Jun; 10(3):254-9.Curr Opin Pharmacol2010-06-01T00:00:002010beta-Adrenoceptor inverse agonists in asthma.20461144Sharafkhaneh A, Petersen NJ, Yu HJ, Dalal AA, Johnson ML, Hanania NAInternational journal of chronic obstructive pulmonary diseaseBurden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010 May 06; 5:125-32.Int J Chron Obstruct Pulmon Dis2010-05-06T00:00:002010Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population.20214460Hanania NA, Donohue JF, Nelson H, Sciarappa K, Goodwin E, Baumgartner RA, Hanrahan JPCOPDThe safety and efficacy of arformoterol and formoterol in COPD. COPD. 2010 Feb; 7(1):17-31.COPD2010-02-01T00:00:002010The safety and efficacy of arformoterol and formoterol in COPD.20226647Hanania NA, Mannino DM, Yawn BP, Mapel DW, Martinez FJ, Donohue JF, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Jhingran P, Dalal AARespiratory medicinePredicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med. 2010 Aug; 104(8):1160-70.Respir Med2010-03-11T00:00:002010Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ).20368906Yawn BP, Mapel DW, Mannino DM, Martinez FJ, Donohue JF, Hanania NA, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Dalal AA, Lung Function Questionnaire Working GroupInternational journal of chronic obstructive pulmonary diseaseDevelopment of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2010 Feb 18; 5:1-10.Int J Chron Obstruct Pulmon Dis2010-02-18T00:00:002010Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction.20889466Hanania NA, Mannava B, Franklin AE, Lipworth BJ, Williamson PA, Garner WJ, Dickey BF, Bond RAThe European respiratory journalResponse to salbutamol in patients with mild asthma treated with nadolol. Eur Respir J. 2010 Oct; 36(4):963-5.Eur Respir J2010-10-01T00:00:002010Response to salbutamol in patients with mild asthma treated with nadolol.Authorship 7020079Authorship 702151228157430Biswas R, Hanania NA, Sabharwal AJournal of aerosol medicine and pulmonary drug deliveryFactors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler. J Aerosol Med Pulm Drug Deliv. 2017 Aug; 30(4):256-266.J Aerosol Med Pulm Drug Deliv2017-02-03T00:00:002017Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.27556408Dransfield MT, Kunisaki KM, Strand MJ, Anzueto A, Bhatt SP, Bowler RP, Criner GJ, Curtis JL, Hanania NA, Nath H, Putcha N, Roark SE, Wan ES, Washko GR, Wells JM, Wendt CH, Make BJ, COPDGene InvestigatorsAmerican journal of respiratory and critical care medicineAcute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017 02 01; 195(3):324-330.Am J Respir Crit Care Med2017-02-01T00:00:002017Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.21566417Hanania NAPostgraduate medicineSafety of chronic obstructive pulmonary disease medications: a primary care perspective. Postgrad Med. 2011 May; 123(3):72-9.Postgrad Med2011-05-01T00:00:002011Safety of chronic obstructive pulmonary disease medications: a primary care perspective.21756032Kim YI, Schroeder J, Lynch D, Newell J, Make B, Friedlander A, Est?par RS, Hanania NA, Washko G, Murphy JR, Wilson C, Hokanson JE, Zach J, Butterfield K, Bowler RPCOPDGender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD. 2011 Aug; 8(4):285-92.COPD2011-07-14T00:00:002011Gender differences of airway dimensions in anatomically matched sites on CT in smokers.21812663Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JGThe New England journal of medicineLebrikizumab treatment in adults with asthma. N Engl J Med. 2011 Sep 22; 365(12):1088-98.N Engl J Med2011-08-03T00:00:002011Lebrikizumab treatment in adults with asthma.20889909Hanania NA, M?llerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, Rennard SI, Sharafkhaneh A, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investiAmerican journal of respiratory and critical care medicineDeterminants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011 Mar 01; 183(5):604-11.Am J Respir Crit Care Med2010-10-01T00:00:002010Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort.22016370Kao CC, Hsu JW, Bandi V, Hanania NA, Kheradmand F, Jahoor FJournal of applied physiology (Bethesda, Md. : 1985)Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease. J Appl Physiol (1985). 2012 Jan; 112(1):42-7.J Appl Physiol (1985)2011-10-20T00:00:002011Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease.22139745Kuhl K, Hanania NACurrent opinion in pulmonary medicineTargeting IgE in asthma. Curr Opin Pulm Med. 2012 Jan; 18(1):1-5.Curr Opin Pulm Med2012-01-01T00:00:002012Targeting IgE in asthma.21045696Mak G, Hanania NACurrent opinion in pulmonary medicineVitamin D and asthma. Curr Opin Pulm Med. 2011 Jan; 17(1):1-5.Curr Opin Pulm Med2011-01-01T00:00:002011Vitamin D and asthma.22385630Tsai CL, Lee WY, Hanania NA, Camargo CAThe Journal of allergy and clinical immunologyAge-related differences in clinical outcomes for acute asthma in the United States, 2006-2008. J Allergy Clin Immunol. 2012 May; 129(5):1252-1258.e1.J Allergy Clin Immunol2012-03-03T00:00:002012Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008.21219660Hanania NA, Sharafkhaneh A, Celli B, Decramer M, Lystig T, Kesten S, Tashkin DRespiratory researchAcute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011 Jan 11; 12:6.Respir Res2011-01-11T00:00:002011Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial.Authorship 7846973Authorship 785457127902500Diamant Z, Hanania NACurrent opinion in pulmonary medicineGeneric medications in precision medicine in asthma. Curr Opin Pulm Med. 2017 01; 23(1):1-2.Curr Opin Pulm Med2017-01-01T00:00:002017Generic medications in precision medicine in asthma.27161908Bujarski S, Parulekar AD, Hanania NAExpert opinion on biological therapyLebrikizumab in the treatment of asthma. Expert Opin Biol Ther. 2016; 16(6):847-852.Expert Opin Biol Ther2016-05-10T00:00:002016Lebrikizumab in the treatment of asthma.21531880Mintz ML, Yawn BP, Mannino DM, Donohue JF, Hanania NA, Grellet CA, Gilsenan AW, McLeod LD, Dalal AA, Raphiou IH, Prillaman BA, Crater GD, Cicale MJ, Mapel DWMayo Clinic proceedingsPrevalence of airway obstruction assessed by lung function questionnaire. Mayo Clin Proc. 2011 May; 86(5):375-81.Mayo Clin Proc2011-05-01T00:00:002011Prevalence of airway obstruction assessed by lung function questionnaire.21636665Han MK, Curran-Everett D, Dransfield MT, Criner GJ, Zhang L, Murphy JR, Hansel NN, DeMeo DL, Hanania NA, Regan EA, Make BJ, Martinez FJ, Westney GE, Foreman MG, COPDGene InvestigatorsChestRacial differences in quality of life in patients with COPD. Chest. 2011 Nov; 140(5):1169-1176.Chest2011-06-02T00:00:002011Racial differences in quality of life in patients with COPD.21697994Drexel C, Jacobson A, Hanania NA, Whitfield B, Katz J, Sullivan TInternational journal of chronic obstructive pulmonary diseaseMeasuring the impact of a live, case-based, multiformat, interactive continuing medical education program on improving clinician knowledge and competency in evidence-based COPD care. Int J Chron Obstruct Pulmon Dis. 2011; 6:297-307.Int J Chron Obstruct Pulmon Dis2011-05-23T00:00:002011Measuring the impact of a live, case-based, multiformat, interactive continuing medical education program on improving clinician knowledge and competency in evidence-based COPD care.23290699Hanania NARespiratory medicineChronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Respir Med. 2012 Dec; 106 Suppl 2:S1-2.Respir Med2012-12-01T00:00:002012Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide.23471469Hanania NA, Wenzel S, Ros?n K, Hsieh HJ, Mosesova S, Choy DF, Lal P, Arron JR, Harris JM, Busse WAmerican journal of respiratory and critical care medicineExploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013 Apr 15; 187(8):804-11.Am J Respir Crit Care Med2013-04-15T00:00:002013Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.23535086Tsai CL, Delclos GL, Huang JS, Hanania NA, Camargo CAAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & ImmunologyAge-related differences in asthma outcomes in the United States, 1988-2006. Ann Allergy Asthma Immunol. 2013 Apr; 110(4):240-6, 246.e1.Ann Allergy Asthma Immunol2013-02-04T00:00:002013Age-related differences in asthma outcomes in the United States, 1988-2006.Authorship 10207122429093COPDGene CT Workshop Group, Barr RG, Berkowitz EA, Bigazzi F, Bode F, Bon J, Bowler RP, Chiles C, Crapo JD, Criner GJ, Curtis JL, Dass C, Dirksen A, Dransfield MT, Edula G, Erikkson L, Friedlander A, Galperin-Aizenberg M, Gefter WB, Gierada DS, Grenier PA, Goldin J, Han MK, Hanania NA, Hansel NN, Jacobson FL, Kauczor HU, Kinnula VL, Lipson DA, Lynch DA, MacNee W, Make BJ, Mamary AJ, Mann H, Marchetti N, Mascalchi M, McLennan G, Murphy JR, Naidich D, Nath H, Newell JD, Pistolesi M, Regan EA, Reilly JJ, Sandhaus R, Schroeder JD, Sciurba F, Shaker S, Sharafkhaneh A, Silverman EK, Steiner RM, Strange C, Sverzellati N, Tashjian JH, van Beek EJ, Washington L, Washko GR, Westney G, Wood SA, Woodruff PGCOPDA combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012 Apr; 9(2):151-9.COPD2012-03-19T00:00:002012A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation.Authorship 869172128395575Hanania NA, Lareau SC, Yawn BPPostgraduate medicineSafety of inhaled long-acting anti-muscarinic agents in COPD. Postgrad Med. 2017 Jun; 129(5):500-512.Postgrad Med2017-04-20T00:00:002017Safety of inhaled long-acting anti-muscarinic agents in COPD.Authorship 869405128427541Hanania NA, Tashkin DP, Kerwin EM, Donohue JF, Denenberg M, O'Donnell DE, Quinn D, Siddiqui S, Orevillo C, Maes A, Reisner CRespiratory medicineLong-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension? Delivery Technology in patients with chronic obstructive pulmonary disease. Respir Med. 2017 05; 126:105-115.Respir Med2017-03-12T00:00:002017Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension? Delivery Technology in patients with chronic obstructive pulmonary disease.8494479Hanania N, Hoffstein VArchives of internal medicineTuberculosis presenting with generalized lymphadenopathy, pulmonary infiltrates, and bone destruction in a young man. Arch Intern Med. 1993 May 24; 153(10):1265-7.Arch Intern Med1993-05-24T00:00:001993Tuberculosis presenting with generalized lymphadenopathy, pulmonary infiltrates, and bone destruction in a young man.European Respiratory Society2016Elected Fellow of European Respiratory Society (FERS) American College of Chest Physicians2016Thomas Petty, MD, Master ACCP Memorial Lecture in COPDAmerican College of Chest Physicians20162013Distinguished Scholar in Respiratory HealthAmerican College of Chest Physicians20142013Member, ACCP/CTS Panel : Acute Exacerbations of COPD GuidelinesAmerican College of Chest Physicians2011Member, ACP/ACCP/ATS/ERS Panel: Clinical Practice Guidelines of COPDAmerican College of Chest Physicians2009Donald Robert McCaffree Humanitarian AwardNational Institute of Health, NHLBI20092005Career Investigator Award (K23)Baylor College of Medicine2003Fulbright and Jaworski L.L.P. Faculty Excellence Award for Teaching and EvaluationBaylor College of Medicine2003Attending of the Year Award, Pulmonary SectionBaylor College of Medicine2003Award for Excellence in Teaching, Department of MedicineNow2011Elected to "Best Doctors in America"Baylor College of Medicine20102003Member, Academy of Distinguished Educators, University of Toronto1994The Toronto Hospital, Department of Medicine, Resident's Research Award (first prize)1995Listed in Marquis Who's Who in America, 50th Edition,American College of Chest Physicians1994Dupont Pharmaceuticals / American College of Chest Physicians - Junior Investigator AwardUniversity of Toronto1993The Toronto Hospital, Department of Medicine, Resident Research Award (third prize)University of Toronto1992University of Toronto, Department of Medicine, Research Award10331126Hanania NA, Zimmerman JLCritical care clinicsAccidental hypothermia. Crit Care Clin. 1999 Apr; 15(2):235-49.Crit Care Clin1999-04-01T00:00:001999Accidental hypothermia.Authorship 103823212016095Hanania NA, Sharafkhaneh A, Barber R, Dickey BFAmerican journal of respiratory and critical care medicineBeta-agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med. 2002 May 15; 165(10):1353-8.Am J Respir Crit Care Med2002-05-15T00:00:002002Beta-agonist intrinsic efficacy: measurement and clinical significance.Authorship 1043013Authorship 87604513Authorship 876167428714735Kaminsky DA, Guntupalli KK, Lippmann J, Burns SM, Brock MA, Skelly J, DeSarno M, Pecott-Grimm H, Mohsin A, LaRock-McMahon C, Warren P, Whitney MC, Hanania NAJournal of alternative and complementary medicine (New York, N.Y.)Effect of Yoga Breathing (Pranayama) on Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Controlled Trial. J Altern Complement Med. 2017 Sep; 23(9):696-704.J Altern Complement Med2017-07-17T00:00:002017Effect of Yoga Breathing (Pranayama) on Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Controlled Trial.28753070Cazzola M, Rogliani P, Calzetta L, Hanania NA, Matera MGCOPDImpact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis. COPD. 2017 Oct; 14(5):552-563.COPD2017-07-28T00:00:002017Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.12970006Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah TChestThe efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest. 2003 Sep; 124(3):834-43.Chest2003-09-01T00:00:002003The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.15379595Hanania NA, Moore RHCurrent drug targets. Inflammation and allergyAnti-inflammatory activities of beta2-agonists. Curr Drug Targets Inflamm Allergy. 2004 Sep; 3(3):271-7.Curr Drug Targets Inflamm Allergy2004-09-01T00:00:002004Anti-inflammatory activities of beta2-agonists.16782375Hanania NAPulmonary pharmacology & therapeuticsRevisiting asthma control: how should it best be defined? Pulm Pharmacol Ther. 2007; 20(5):483-92.Pulm Pharmacol Ther2006-05-12T00:00:002006Revisiting asthma control: how should it best be defined?17157651McCoy K, Shade DM, Irvin CG, Mastronarde JG, Hanania NA, Castro M, Anthonisen NR, American Lung Association Asthma Clinical Research CentersThe Journal of allergy and clinical immunologyPredicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol. 2006 Dec; 118(6):1226-33.J Allergy Clin Immunol2006-10-23T00:00:002006Predicting episodes of poor asthma control in treated patients with asthma.17364671Rebbapragada V, Hanania NACOPDCan we predict depression in COPD? COPD. 2007 Mar; 4(1):3-4.COPD2007-03-01T00:00:002007Can we predict depression in COPD?17472819Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JPClinical therapeuticsNebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. Clin Ther. 2007 Feb; 29(2):261-78.Clin Ther2007-02-01T00:00:002007Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.17878465Hanania NA, Donohue JFProceedings of the American Thoracic SocietyPharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators. Proc Am Thorac Soc. 2007 Oct 01; 4(7):526-34.Proc Am Thorac Soc2007-10-01T00:00:002007Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators.18453358Sharafkhaneh A, Hanania NA, Kim VProceedings of the American Thoracic SocietyPathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc. 2008 May 01; 5(4):475-7.Proc Am Thorac Soc2008-05-01T00:00:002008Pathogenesis of emphysema: from the bench to the bedside.Authorship 8776257Authorship 8776265Authorship 8776272Authorship 87762817Authorship 8776292Authorship 8776301Authorship 8776313Authorship 8776326Authorship 8776333Authorship 8776348Authorship 8776352Authorship 8776364Authorship 8776376Authorship 8776383Authorship 8776393Authorship 877640429217605Bousquet J, Brusselle G, Buhl R, Busse WW, Cruz AA, Djukanovic R, Domingo C, Hanania NA, Humbert M, Menzies Gow A, Phipatanakul W, Wahn U, Wechsler METhe European respiratory journalCare pathways for the selection of a biologic in severe asthma. Eur Respir J. 2017 12; 50(6).Eur Respir J2017-12-07T00:00:002017Care pathways for the selection of a biologic in severe asthma.29206640Goto T, Faridi MK, Gibo K, Toh S, Hanania NA, Camargo CA, Hasegawa KRespiratory medicineTrends in 30-day readmission rates after COPD hospitalization, 2006-2012. Respir Med. 2017 Sep; 130:92-97.Respir Med2017-07-26T00:00:002017Trends in 30-day readmission rates after COPD hospitalization, 2006-2012.29192825Narendra DK, Hanania NAAnnals of the American Thoracic SocietyProcalcitonin in Chronic Obstructive Pulmonary Disease Exacerbations: Is It Ready for Primetime Use? Ann Am Thorac Soc. 2017 12; 14(12):1757-1758.Ann Am Thorac Soc2017-12-01T00:00:002017Procalcitonin in Chronic Obstructive Pulmonary Disease Exacerbations: Is It Ready for Primetime Use?29169736Parulekar AD, Martinez C, Tsai CL, Locantore N, Atik M, Yohannes AM, Kao CC, Al-Azzawi H, Mohsin A, Wise RA, Foreman MG, Demeo DL, Regan EA, Make BJ, Boriek AM, Wiener LE, Hanania NAJournal of the American Medical Directors AssociationExamining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts. J Am Med Dir Assoc. 2017 Dec 01; 18(12):1063-1068.J Am Med Dir Assoc2017-12-01T00:00:002017Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.29059087Humbert M, Busse W, Hanania NACurrent opinion in pulmonary medicineControversies and opportunities in severe asthma. Curr Opin Pulm Med. 2018 01; 24(1):83-93.Curr Opin Pulm Med2018-01-01T00:00:002018Controversies and opportunities in severe asthma.29045293Hanania NA, Diamant ZCurrent opinion in pulmonary medicineThe road to precision medicine in asthma: challenges and opportunities. Curr Opin Pulm Med. 2018 01; 24(1):1-3.Curr Opin Pulm Med2018-01-01T00:00:002018The road to precision medicine in asthma: challenges and opportunities.29036019Parulekar AD, Kao CC, Diamant Z, Hanania NACurrent opinion in pulmonary medicineTargeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs. Curr Opin Pulm Med. 2018 01; 24(1):50-55.Curr Opin Pulm Med2018-01-01T00:00:002018Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.28974349Rogers L, Sugar EA, Blake K, Castro M, Dimango E, Hanania NA, Happel KI, Peters SP, Reibman J, Saams J, Teague WG, Wise RA, Holbrook JT, American Lung Association Airways Clinical Research CentersThe journal of allergy and clinical immunology. In practiceStep-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):633-643.e1.J Allergy Clin Immunol Pract2017-09-30T00:00:002017Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial.28929293Medrek SK, Parulekar AD, Hanania NACurrent allergy and asthma reportsPredictive Biomarkers for Asthma Therapy. Curr Allergy Asthma Rep. 2017 Sep 19; 17(10):69.Curr Allergy Asthma Rep2017-09-19T00:00:002017Predictive Biomarkers for Asthma Therapy.28903915Boriek AM, Lopez MA, Velasco C, Bakir AA, Frolov A, Wynd S, Babb TG, Hanania NA, Hoffman EA, Sharafkhaneh AAmerican journal of physiology. Regulatory, integrative and comparative physiologyObesity modulates diaphragm curvature in subjects with and without COPD. Am J Physiol Regul Integr Comp Physiol. 2017 Nov 01; 313(5):R620-R629.Am J Physiol Regul Integr Comp Physiol2017-09-13T00:00:002017Obesity modulates diaphragm curvature in subjects with and without COPD.28868931Monaco TJ, Hanania NAExpert opinion on emerging drugsEmerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD. Expert Opin Emerg Drugs. 2017 09; 22(3):285-299.Expert Opin Emerg Drugs2017-09-03T00:00:002017Emerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD.28759275Mangold R, Salzman GA, Williams KB, Hanania NAThe Journal of asthma : official journal of the Association for the Care of AsthmaFactors associated with depressive symptoms in uncontrolled asthmatics. J Asthma. 2018 05; 55(5):555-560.J Asthma2017-09-07T00:00:002017Factors associated with depressive symptoms in uncontrolled asthmatics.28733182Yohannes AM, M?lerov? H, Lavoie K, Vestbo J, Rennard SI, Wouters E, Hanania NAJournal of the American Medical Directors AssociationThe Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort. J Am Med Dir Assoc. 2017 Nov 01; 18(11):955-959.e6.J Am Med Dir Assoc2017-07-18T00:00:002017The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.28853450Sethi S, Fogarty C, Hanania NA, Martinez FJ, Rennard S, Fries M, Orevillo C, Darken P, St Rose E, Strom S, Fischer T, Golden M, Dwivedi S, Reisner CChronic obstructive pulmonary diseases (Miami, Fla.)Erratum: Erratum: Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension? Delivery Technology Versus Foradil? Aerolizer? in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study. Chronic Obstr Pulm Dis. 2017 Apr 15; 4(3):258.Chronic Obstr Pulm Dis2017-04-15T00:00:002017Erratum: Erratum: Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension? Delivery Technology Versus Foradil? Aerolizer? in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study.28848908Sethi S, Fogarty C, Hanania NA, Martinez FJ, Rennard S, Fries M, Orevillo C, Darken P, St Rose E, Strom S, Fischer T, Golden M, Dwivedi S, Reisner CChronic obstructive pulmonary diseases (Miami, Fla.)Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension? Delivery Technology Versus Foradil? Aerolizer? in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study. Chronic Obstr Pulm Dis. 2016 Nov 17; 4(1):21-33.Chronic Obstr Pulm Dis2016-11-17T00:00:002016Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension? Delivery Technology Versus Foradil? Aerolizer? in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study.28848907Wise RA, Acevedo RA, Anzueto AR, Hanania NA, Martinez FJ, Ohar JA, Tashkin DPChronic obstructive pulmonary diseases (Miami, Fla.)Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus. Chronic Obstr Pulm Dis. 2016 Nov 15; 4(1):7-20.Chronic Obstr Pulm Dis2016-11-15T00:00:002016Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.19085584Guntupalli KK, Reddy RM, Loutfi RH, Alapat PM, Bandi VD, Hanania NAThe Journal of asthma : official journal of the Association for the Care of AsthmaEvaluation of obstructive lung disease with vibration response imaging. J Asthma. 2008 Dec; 45(10):923-30.J Asthma2008-12-01T00:00:002008Evaluation of obstructive lung disease with vibration response imaging.19124372Donohue JF, Hanania NA, Fogarty C, Campbell SC, Rinehart M, Denis-Mize KTherapeutic advances in respiratory diseaseLong-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial. Ther Adv Respir Dis. 2008 Aug; 2(4):199-208.Ther Adv Respir Dis2008-08-01T00:00:002008Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial.Authorship 105768319492178Bailey WC, Sciurba FC, Hanania NA, Donohue JF, Ferguson GT, Zibrak JD, Sharafkhaneh A, Marcus P, Rosa K, Piault EC, Martinez FJPrimary care respiratory journal : journal of the General Practice Airways GroupDevelopment and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J. 2009 Sep; 18(3):198-207.Prim Care Respir J2009-09-01T00:00:002009Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ).19887938Hanania NA, Dickey BF, Bond RACurrent opinion in pulmonary medicineClinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism. Curr Opin Pulm Med. 2010 Jan; 16(1):1-5.Curr Opin Pulm Med2010-01-01T00:00:002010Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism.19953349Tashkin DP, Hanania NA, McGinty J, Denis-Mize K, Chaudry IAdvances in therapyNebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Adv Ther. 2009 Nov; 26(11):1024-34.Adv Ther2009-12-02T00:00:002009Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.20941660Hanania NA, Sharma G, Sharafkhaneh ASeminars in respiratory and critical care medicineCOPD in the elderly patient. Semin Respir Crit Care Med. 2010 Oct; 31(5):596-606.Semin Respir Crit Care Med2010-10-12T00:00:002010COPD in the elderly patient.21175591Walker JK, Penn RB, Hanania NA, Dickey BF, Bond RABritish journal of pharmacologyNew perspectives regarding ?(2) -adrenoceptor ligands in the treatment of asthma. Br J Pharmacol. 2011 May; 163(1):18-28.Br J Pharmacol2011-05-01T00:00:002011New perspectives regarding ?(2) -adrenoceptor ligands in the treatment of asthma.21536936Hanania NA, Alpan O, Hamilos DL, Condemi JJ, Reyes-Rivera I, Zhu J, Rosen KE, Eisner MD, Wong DA, Busse WAnnals of internal medicineOmalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial. Ann Intern Med. 2011 05 03; 154(9):573-82.Ann Intern Med2011-05-03T00:00:002011Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.21684731Dalal AA, Shah M, Lunacsek O, Hanania NARespiratory medicineClinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease. Respir Med. 2011 Oct; 105(10):1516-22.Respir Med2011-10-01T00:00:002011Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease.21704887Castro M, Rubin A, Laviolette M, Hanania NA, Armstrong B, Cox G, AIR2 Trial Study GroupAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & ImmunologyPersistence of effectiveness of bronchial thermoplasty in patients with severe asthma. Ann Allergy Asthma Immunol. 2011 Jul; 107(1):65-70.Ann Allergy Asthma Immunol2011-04-14T00:00:002011Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma.21810710Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Sch?nemann H, Wedzicha W, MacDonald R, Shekelle P, American College of Physicians, American College of Chest Physicians, American Thoracic Society, European Respiratory SocietyAnnals of internal medicineDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011 Aug 02; 155(3):179-91.Ann Intern Med2011-08-02T00:00:002011Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.22040533Hanania NA, Crater GD, Morris AN, Emmett AH, O'Dell DM, Niewoehner DERespiratory medicineBenefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD. Respir Med. 2012 Jan; 106(1):91-101.Respir Med2011-10-29T00:00:002011Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD.22196881Tamimi A, Serdarevic D, Hanania NARespiratory medicineThe effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir Med. 2012 Mar; 106(3):319-28.Respir Med2011-12-22T00:00:002011The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.22241764Hanania NA, Feldman G, Zachgo W, Shim JJ, Crim C, Sanford L, Lettis S, Barnhart F, Haumann BChestThe efficacy and safety of the novel long-acting ?2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial. Chest. 2012 Jul; 142(1):119-127.Chest2012-07-01T00:00:002012The efficacy and safety of the novel long-acting ?2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial.22445544Mak G, Hanania NACurrent opinion in pharmacologyNew bronchodilators. Curr Opin Pharmacol. 2012 Jun; 12(3):238-45.Curr Opin Pharmacol2012-03-21T00:00:002012New bronchodilators.22913289Al-shair K, Muellerova H, Yorke J, Rennard SI, Wouters EF, Hanania NA, Sharafkhaneh A, Vestbo J, ECLIPSE investigatorsHealth and quality of life outcomesExamining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes. 2012 Aug 23; 10:100.Health Qual Life Outcomes2012-08-23T00:00:002012Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale.22958990Adams SG, Pitts J, Wynne J, Yawn BP, Diamond EJ, Lee S, Dellert E, Hanania NAMayo Clinic proceedingsEffect of a primary care continuing education program on clinical practice of chronic obstructive pulmonary disease: translating theory into practice. Mayo Clin Proc. 2012 Sep; 87(9):862-70.Mayo Clin Proc2012-09-01T00:00:002012Effect of a primary care continuing education program on clinical practice of chronic obstructive pulmonary disease: translating theory into practice.Authorship 8778314Authorship 8778324Authorship 8778333Authorship 8778343Authorship 8778357Authorship 8778362Authorship 877837129559537Dhand R, Mahler DA, Carlin BW, Hanania NA, Ohar JA, Pinto-Plata V, Shah T, Eubanks D, Braman SSRespiratory careResults of a Patient Survey Regarding COPD Knowledge, Treatment Experiences, and Practices With Inhalation Devices. Respir Care. 2018 07; 63(7):833-839.Respir Care2018-03-20T00:00:002018Results of a Patient Survey Regarding COPD Knowledge, Treatment Experiences, and Practices With Inhalation Devices.29528249Cazzola M, Calzetta L, Matera MG, Hanania NA, Rogliani PExpert opinion on drug metabolism & toxicologyHow does race/ethnicity influence pharmacological response to asthma therapies? Expert Opin Drug Metab Toxicol. 2018 Apr; 14(4):435-446.Expert Opin Drug Metab Toxicol2018-03-12T00:00:002018How does race/ethnicity influence pharmacological response to asthma therapies?29494328Yohannes AM, Kaplan A, Hanania NACleveland Clinic journal of medicineAnxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management. Cleve Clin J Med. 2018 Feb; 85(2 Suppl 1):S11-S18.Cleve Clin J Med2018-02-01T00:00:002018Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management.29443332Yohannes AM, Kaplan A, Hanania NAThe Journal of family practiceCOPD in Primary Care: Key Considerations for Optimized Management: Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management. J Fam Pract. 2018 02; 67(2 Suppl):S11-S18.J Fam Pract2018-02-01T00:00:002018COPD in Primary Care: Key Considerations for Optimized Management: Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management.29440887Donohue JF, Bollu VK, Stull DE, Nelson LM, Williams VS, Stensland MD, Hanania NAInternational journal of chronic obstructive pulmonary diseaseLong-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial. Int J Chron Obstruct Pulmon Dis. 2018; 13:499-508.Int J Chron Obstruct Pulmon Dis2018-02-05T00:00:002018Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.29411337Braddock M, Hanania NA, Sharafkhaneh A, Colice G, Carlsson MDrug safetyPotential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review. Drug Saf. 2018 05; 41(5):489-509.Drug Saf2018-05-01T00:00:002018Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review.29408317Hanania NA, Massanari M, Jain NAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & ImmunologyMeasurement of fractional exhaled nitric oxide in real-world clinical practice alters asthma treatment decisions. Ann Allergy Asthma Immunol. 2018 04; 120(4):414-418.e1.Ann Allergy Asthma Immunol2018-04-01T00:00:002018Measurement of fractional exhaled nitric oxide in real-world clinical practice alters asthma treatment decisions.23196270Parulekar AD, Alobaidy A, Hanania NACurrent opinion in pulmonary medicineAsthma outcomes revisited. Curr Opin Pulm Med. 2013 Jan; 19(1):6-12.Curr Opin Pulm Med2013-01-01T00:00:002013Asthma outcomes revisited.Authorship 8795328Authorship 884192328859263Casale TB, Chipps BE, Ros?n K, Trzaskoma B, Haselkorn T, Omachi TA, Greenberg S, Hanania NAAllergyResponse to omalizumab using patient enrichment criteria from trials of novel biologics in asthma. Allergy. 2018 02; 73(2):490-497.Allergy2017-09-23T00:00:002017Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma.29717099Braman SS, Carlin BW, Hanania NA, Mahler DA, Ohar JA, Pinto-Plata V, Shah T, Eubanks D, Dhand RRespiratory careResults of a Pulmonologist Survey Regarding Knowledge and Practices With Inhalation Devices for COPD. Respir Care. 2018 07; 63(7):840-848.Respir Care2018-05-01T00:00:002018Results of a Pulmonologist Survey Regarding Knowledge and Practices With Inhalation Devices for COPD.23378756Decramer ML, Hanania NA, L?tvall JO, Yawn BPInternational journal of chronic obstructive pulmonary diseaseThe safety of long-acting ?2-agonists in the treatment of stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013; 8:53-64.Int J Chron Obstruct Pulmon Dis2013-01-25T00:00:002013The safety of long-acting ?2-agonists in the treatment of stable chronic obstructive pulmonary disease.23413893Hansel NN, Washko GR, Foreman MG, Han MK, Hoffman EA, DeMeo DL, Barr RG, Van Beek EJ, Kazerooni EA, Wise RA, Brown RH, Black-Shinn J, Hokanson JE, Hanania NA, Make B, Silverman EK, Crapo JD, Dransfield MT, COPDGene InvestigatorsCOPDRacial differences in CT phenotypes in COPD. COPD. 2013 Feb; 10(1):20-7.COPD2013-02-01T00:00:002013Racial differences in CT phenotypes in COPD.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1InstructorInstructortrue1Associate ProfessorAssociate ProfessorAuthorship 1018714D029424Disorders21010180.512027Pulmonary Disease, Chronic ObstructiveD001993Chemicals & DrugsPhysiology672190.830573Bronchodilator AgentsD018927Chemicals & Drugs501180.866127Anti-Asthmatic AgentsAuthorship 1081904D001249Disorders2558670.547657AsthmaAuthorship 9204622Authorship 92063015Authorship 9304782Authorship 9332705Authorship 9332715Authorship 9333621Authorship 9337214Authorship 9365283Authorship 9370941Authorship 9380484Authorship 9385882Authorship 9397731Authorship 940275130077690Maselli DJ, Hardin M, Christenson SA, Hanania NA, Hersh CP, Adams SG, Anzueto A, Peters JI, Han MK, Martinez FJChestClinical Approach to the Therapy of Asthma-COPD Overlap. Chest. 2019 01; 155(1):168-177.Chest2018-08-02T00:00:002018Clinical Approach to the Therapy of Asthma-COPD Overlap.29986152Baker AM, Holbrook JT, Yohannes AM, Eakin MN, Sugar EA, Henderson RJ, Casper AS, Kaminsky DA, Rea AL, Mathews AM, Que LG, Ramsdell JW, Gerald LB, Wise RA, Hanania NA, American Lung Association Airways Clinical Research CentersAnnals of the American Thoracic SocietyTest Performance Characteristics of the AIR, GAD-7, and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2018 Aug; 15(8):926-934.Ann Am Thorac Soc2018-08-01T00:00:002018Test Performance Characteristics of the AIR, GAD-7, and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease.30172866Maselli DJ, Hanania NAPulmonary pharmacology & therapeuticsAsthma COPD overlap: Impact of associated comorbidities. Pulm Pharmacol Ther. 2018 10; 52:27-31.Pulm Pharmacol Ther2018-08-30T00:00:002018Asthma COPD overlap: Impact of associated comorbidities.30219705Calzetta L, Hanania NA, Dini FL, Goldstein MF, Fairweather WR, Howard WW, Cazzola MPulmonary pharmacology & therapeuticsImpact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2). Pulm Pharmacol Ther. 2018 12; 53:20-26.Pulm Pharmacol Ther2018-09-13T00:00:002018Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2).30233171D'Urzo AD, Cazzola M, Hanania NA, Buhl R, Maleki-Yazdi MRInternational journal of chronic obstructive pulmonary diseaseNew developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology. Int J Chron Obstruct Pulmon Dis. 2018; 13:2805-2819.Int J Chron Obstruct Pulmon Dis2018-09-07T00:00:002018New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology.30290933Han MK, Hanania NA, Martinez FJChestConfronting the Challenge of COPD: What Is New in the Approaches to Diagnosis, Treatment, and Patient Outcomes. Chest. 2018 10; 154(4):984-985.Chest2018-10-01T00:00:002018Confronting the Challenge of COPD: What Is New in the Approaches to Diagnosis, Treatment, and Patient Outcomes.30422894Diamant Z, Aalders W, Parulekar A, Bjermer L, Hanania NACurrent opinion in pulmonary medicineTargeting lipid mediators in asthma: time for reappraisal. Curr Opin Pulm Med. 2019 01; 25(1):121-127.Curr Opin Pulm Med2019-01-01T00:00:002019Targeting lipid mediators in asthma: time for reappraisal.30423008Skolnik N, Kaplan AG, Lake T, Hayden ML, Hanania NAThe Journal of family practiceCOPD Management in the Primary Care Setting. J Fam Pract. 2018 10; 67(10 Suppl):S27-S32.J Fam Pract2018-10-01T00:00:002018COPD Management in the Primary Care Setting.30590505Shaddox E, Peterson CB, Stingo FC, Hanania NA, Cruickshank-Quinn C, Kechris K, Bowler R, Vannucci MBiostatistics (Oxford, England)Bayesian inference of networks across multiple sample groups and data types. Biostatistics. 2020 07 01; 21(3):561-576.Biostatistics2020-07-01T00:00:002020Bayesian inference of networks across multiple sample groups and data types.30576755Hanania NA, Chipps BE, Griffin NM, Yoo B, Iqbal A, Casale TBThe Journal of allergy and clinical immunologyOmalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO. J Allergy Clin Immunol. 2019 04; 143(4):1629-1633.e2.J Allergy Clin Immunol2018-12-18T00:00:002018Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO.30643398Hanania NA, Sethi S, Koltun A, Ward JK, Spanton J, Ng DInternational journal of chronic obstructive pulmonary diseaseLong-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:117-127.Int J Chron Obstruct Pulmon Dis2018-12-27T00:00:002018Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD.30461532Boulet LP, Hanania NACurrent opinion in pulmonary medicineThe many faces of asthma-chronic obstructive pulmonary disease overlap. Curr Opin Pulm Med. 2019 01; 25(1):1-10.Curr Opin Pulm Med2019-01-01T00:00:002019The many faces of asthma-chronic obstructive pulmonary disease overlap.30374449Hanania NA, Braman S, Adams SG, Adewuya R, Ari A, Brooks J, Mahler DA, Ohar JA, Peters J, Sanjar SChronic obstructive pulmonary diseases (Miami, Fla.)The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers. Chronic Obstr Pulm Dis. 2018 Apr 01; 5(2):111-123.Chronic Obstr Pulm Dis2018-04-01T00:00:002018The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers.2016-07-31NIHHANANIA, NICOLA A2011-08-15Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol in Mild AsthmaU01AI0950502009-08-31NIHHANANIA, NICOLA A2005-09-06Response to Beta2-Agonists in Acute Severe AsthmaK23HL079054Principal InvestigatorPrincipal InvestigatorPharmacological & Pharmaceutical SciencesDepartment of MedicineDepartment of Orthopedic SurgeryDepartment of PediatricsDepartment of SurgerySurgery-Transplant DivisionMedicine-General MedicineMedicine-PulmonaryOrthopedic SurgeryPediatrics-PulmonaryBaylor College of MedicineUniversity of Houston College of PharmacySHARONCHENSHARON CHEN29.70990600000000-95.402830000000001066CHEN, SHARONAssistant ProfessorHAROLDFARBERHAROLD FARBER0.000000000000000.000000000000001299FARBER, HAROLDProfessorMELVYNHARRINGTON JRMELVYN HARRINGTON JR29.70990600000000-95.402830000000001264HARRINGTON JR, MELVYNProfessor27.83950.00466287630research areas3.90660.013459858coauthor of1393.9345.116560similar to11316selected publicationsJAMESKELAHERJAMES KELAHER29.70990600000000-95.402830000000002032KELAHER, JAMESAssociate ProfessorAMIRSHARAFKHANEHAMIR SHARAFKHANEH29.70508570000000-95.401808700000002082SHARAFKHANEH, AMIRProfessorRICHARDBONDRICHARD A. BOND29.72602660000000-95.348164100000004618BOND, RICHARDProfessorCHRISTINEO'MAHONYCHRISTINE O'MAHONY29.70990600000000-95.40283000000000781O'MAHONY, CHRISTINEAssociate ProfessorMUSTAFAATIKMUSTAFA ATIK29.70990600000000-95.40283000000000807ATIK, MUSTAFAInstructorAuthorship 94155015Authorship 942094330594559Yohannes AM, Dryden S, Hanania NAChestValidity and Responsiveness of the?Depression Anxiety Stress Scales-21?(DASS-21) in?COPD. Chest. 2019 06; 155(6):1166-1177.Chest2018-12-27T00:00:002018Validity and Responsiveness of the?Depression Anxiety Stress Scales-21?(DASS-21) in?COPD.30782350Iyer AS, Holm KE, Bhatt SP, Kim V, Kinney GL, Wamboldt FS, Jacobs MR, Regan EA, Armstrong HF, Lowe KE, Martinez CH, Dransfield MT, Foreman MG, Shinozaki G, Hanania NA, Wise RA, Make BJ, Hoth KF, COPDGene InvestigatorsJournal of psychosomatic researchSymptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort. J Psychosom Res. 2019 03; 118:18-26.J Psychosom Res2019-01-07T00:00:002019Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort.Authorship 944859230962155Pavord ID, Hanania NAThe journal of allergy and clinical immunology. In practiceControversies in Allergy: Should Severe Asthma with Eosinophilic Phenotype Always Be Treated with Anti-IL-5 Therapies. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1430-1436.J Allergy Clin Immunol Pract2019-04-05T00:00:002019Controversies in Allergy: Should Severe Asthma with Eosinophilic Phenotype Always Be Treated with Anti-IL-5 Therapies.Authorship 945472430998908Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig MChestRadiation-Induced Lung Injury: Assessment and Management. Chest. 2019 07; 156(1):150-162.Chest2019-04-15T00:00:002019Radiation-Induced Lung Injury: Assessment and Management.Authorship 1110661Authorship 1271384D058666Chemicals & Drugs361060.89809Adrenergic beta-2 Receptor AgonistsAuthorship 128558123875742Sharafkhaneh A, Wolf RA, Goodnight S, Hanania NA, Make BJ, Tashkin DPCOPDPerceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives. COPD. 2013 Aug; 10(4):482-92.COPD2013-04-05T00:00:002013Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives.24081347Hanania NAChestEvaluating the safety of COPD medications: an evidence-based review. Chest. 2013 Oct; 144(4):1357-1367.Chest2013-10-01T00:00:002013Evaluating the safety of COPD medications: an evidence-based review.Authorship 9475403Authorship 94833010Authorship 948403231114270Brooks EA, Massanari M, Hanania NA, Weiner DJClinicoEconomics and outcomes research : CEORCost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma. Clinicoecon Outcomes Res. 2019; 11:301-307.Clinicoecon Outcomes Res2019-04-17T00:00:002019Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma.31169594Assaf SM, Hanania NACurrent opinion in allergy and clinical immunologyBiological treatments for severe asthma. Curr Opin Allergy Clin Immunol. 2019 08; 19(4):379-386.Curr Opin Allergy Clin Immunol2019-08-01T00:00:002019Biological treatments for severe asthma.31154041Maselli DJ, Bhatt SP, Anzueto A, Bowler RP, DeMeo DL, Diaz AA, Dransfield MT, Fawzy A, Foreman MG, Hanania NA, Hersh CP, Kim V, Kinney GL, Putcha N, Wan ES, Wells JM, Westney GE, Young KA, Silverman EK, Han MK, Make BJChestClinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study. Chest. 2019 08; 156(2):228-238.Chest2019-05-30T00:00:002019Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.true1ProfessorProfessorAuthorship 949027231190789Narendra DK, Hanania NAInternational journal of chronic obstructive pulmonary diseaseTargeting IL-5 in COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:1045-1051.Int J Chron Obstruct Pulmon Dis2019-05-16T00:00:002019Targeting IL-5 in COPD.Authorship 949521131213793Hanania NA, O'Donnell DEInternational journal of chronic obstructive pulmonary diseaseActivity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. Int J Chron Obstruct Pulmon Dis. 2019; 14:1127-1138.Int J Chron Obstruct Pulmon Dis2019-05-24T00:00:002019Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions.Authorship 1104472Authorship 950407431228775Rogliani P, Matera MG, Calzetta L, Hanania NA, Page C, Rossi I, Andreadi A, Galli A, Coppola A, Cazzola M, Lauro DRespiratory medicineLong-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients. Respir Med. 2019 Jul - Aug; 154:86-92.Respir Med2019-06-18T00:00:002019Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients.Authorship 952489631336178Li P, Kavati A, Puckett JT, Jahnke J, Busse P, Hanania NA, Ortiz B, Doshi JAThe journal of allergy and clinical immunology. In practiceOmalizumab Treatment Patterns Among Patients with Asthma in the US Medicare Population. J Allergy Clin Immunol Pract. 2020 02; 8(2):507-515.e10.J Allergy Clin Immunol Pract2019-07-20T00:00:002019Omalizumab Treatment Patterns Among Patients with Asthma in the US Medicare Population.Authorship 953256231376487Maselli DJ, Hanania NAAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & ImmunologyManagement of asthma COPD overlap. Ann Allergy Asthma Immunol. 2019 10; 123(4):335-344.Ann Allergy Asthma Immunol2019-07-31T00:00:002019Management of asthma COPD overlap.Authorship 110992Authorship 1111021Authorship 955565431521831Corren J, Castro M, O'Riordan T, Hanania NA, Pavord ID, Quirce S, Chipps BE, Wenzel SE, Thangavelu K, Rice MS, Harel S, Jagerschmidt A, Khan AH, Kamat S, Maroni J, Rowe P, Lu Y, Amin N, Pirozzi G, Ruddy M, Graham NMH, Teper AThe journal of allergy and clinical immunology. In practiceDupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma. J Allergy Clin Immunol Pract. 2020 02; 8(2):516-526.J Allergy Clin Immunol Pract2019-09-12T00:00:002019Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.Authorship 1127555Authorship 1128412Authorship 957742231644440Ulrik CS, Vijverberg S, Hanania NA, Diamant ZCurrent opinion in pulmonary medicinePrecision medicine and treatable traits in chronic airway diseases - where do we stand? Curr Opin Pulm Med. 2020 01; 26(1):33-39.Curr Opin Pulm Med2020-01-01T00:00:002020Precision medicine and treatable traits in chronic airway diseases - where do we stand?true1ProfessorProfessorAuthorship 960624331695862Yohannes AM, Dryden S, Hanania NATherapeutic advances in chronic diseaseThe responsiveness of the Manchester Chronic Obstructive Pulmonary Disease Fatigue Scale to pulmonary rehabilitation. Ther Adv Chronic Dis. 2019; 10:2040622319882206.Ther Adv Chronic Dis2019-10-29T00:00:002019The responsiveness of the Manchester Chronic Obstructive Pulmonary Disease Fatigue Scale to pulmonary rehabilitation.Authorship 96084841Authorship 961026331710793Lowe KE, Regan EA, Anzueto A, Austin E, Austin JHM, Beaty TH, Benos PV, Benway CJ, Bhatt SP, Bleecker ER, Bodduluri S, Bon J, Boriek AM, Boueiz AR, Bowler RP, Budoff M, Casaburi R, Castaldi PJ, Charbonnier JP, Cho MH, Comellas A, Conrad D, Costa Davis C, Criner GJ, Curran-Everett D, Curtis JL, DeMeo DL, Diaz AA, Dransfield MT, Dy JG, Fawzy A, Fleming M, Flenaugh EL, Foreman MG, Fortis S, Gebrekristos H, Grant S, Grenier PA, Gu T, Gupta A, Han MK, Hanania NA, Hansel NN, Hayden LP, Hersh CP, Hobbs BD, Hoffman EA, Hogg JC, Hokanson JE, Hoth KF, Hsiao A, Humphries S, Jacobs K, Jacobson FL, Kazerooni EA, Kim V, Kim WJ, Kinney GL, Koegler H, Lutz SM, Lynch DA, MacIntye NR, Make BJ, Marchetti N, Martinez FJ, Maselli DJ, Mathews AM, McCormack MC, McDonald MN, McEvoy CE, Moll M, Molye SS, Murray S, Nath H, Newell JD, Occhipinti M, Paoletti M, Parekh T, Pistolesi M, Pratte KA, Putcha N, Ragland M, Reinhardt JM, Rennard SI, Rosiello RA, Ross JC, Rossiter HB, Ruczinski I, San Jose Estepar R, Sciurba FC, Sieren JC, Singh H, Soler X, Steiner RM, Strand MJ, Stringer WW, Tal-Singer R, Thomashow B, Vegas S?nchez-Ferrero G, Walsh JW, Wan ES, Washko GR, Michael Wells J, Wendt CH, Westney G, Wilson A, Wise RA, Yen A, Young K, Yun J, Silverman EK, Crapo JDChronic obstructive pulmonary diseases (Miami, Fla.)COPDGene? 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis. 2019 Nov; 6(5):384-399.Chronic Obstr Pulm Dis2019-11-01T00:00:002019COPDGene? 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.31724963Diamant Z, van den Berge M, Hanania NACurrent opinion in pulmonary medicineEditorial: Asthma: a modifiable disease on a crossroad. Curr Opin Pulm Med. 2020 01; 26(1):1-2.Curr Opin Pulm Med2020-01-01T00:00:002020Editorial: Asthma: a modifiable disease on a crossroad.Authorship 961193331735516Narendra D, Blixt J, Hanania NASeminars in immunologyImmunological biomarkers in severe asthma. Semin Immunol. 2019 12; 46:101332.Semin Immunol2019-11-14T00:00:002019Immunological biomarkers in severe asthma.Authorship 962289231812201Hanania AN, Hanania NAChestResponse. Chest. 2019 12; 156(6):1276.Chest2019-12-01T00:00:002019Response.Authorship 962932431860333Myers LC, Faridi MK, Hasegawa K, Hanania NA, Camargo CAAnnals of the American Thoracic SocietyThe Hospital Readmissions Reduction Program and Readmissions for Chronic Obstructive Pulmonary Disease, 2006-2015. Ann Am Thorac Soc. 2020 04; 17(4):450-456.Ann Am Thorac Soc2020-04-01T00:00:002020The Hospital Readmissions Reduction Program and Readmissions for Chronic Obstructive Pulmonary Disease, 2006-2015.Authorship 976332231980492Bachert C, Humbert M, Hanania NA, Zhang N, Holgate S, Buhl R, Br?ker BMThe European respiratory journalStaphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge. Eur Respir J. 2020 04; 55(4).Eur Respir J2020-04-03T00:00:002020Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge.Authorship 976473131981731Hanania NA, Djukanovic R, Heaney LG, Yang M, Yoo B, Iqbal A, Griffin NM, Chipps BEThe journal of allergy and clinical immunology. In practiceDeterminants of lung function improvement with omalizumab in adults with allergic asthma. J Allergy Clin Immunol Pract. 2020 06; 8(6):2068-2070.J Allergy Clin Immunol Pract2020-01-22T00:00:002020Determinants of lung function improvement with omalizumab in adults with allergic asthma.Authorship 9776211432034960Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hamelmann E, Hanania N, M?kel? M, Hern?ndez-Mart?n I, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, P?rez de Llano L, Posso M, Rocha C, Quirce S, Sastre J, Shamji M, Song Y, Steiner C, Schwarze J, Alonso-Coello P, Palomares O, Jutel MAllergyEfficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020 05; 75(5):1023-1042.Allergy2020-02-24T00:00:002020Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.Authorship 977848632048241Rogliani P, Calzetta L, Matera MG, Laitano R, Ritondo BL, Hanania NA, Cazzola MPulmonary therapySevere Asthma and Biological Therapy: When, Which, and for Whom. Pulm Ther. 2020 Jun; 6(1):47-66.Pulm Ther2019-12-26T00:00:002019Severe Asthma and Biological Therapy: When, Which, and for Whom.Authorship 9782741732064642Agache I, Rocha C, Beltran J, Song Y, Posso M, Sol? I, Alonso-Coello P, Akdis C, Akdis M, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hamelmann E, Hanania N, M?kel? M, Mart?n IH, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, P?rez de Llano L, Quirce S, Sastre J, Shamji M, Schwarze J, Canelo-Aybar C, Palomares O, Jutel MAllergyEfficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020 05; 75(5):1043-1057.Allergy2020-05-01T00:00:002020Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.Authorship 1146163Authorship 9789493Authorship 9790061832151753Bruhl RJ, Perkison WB, Hanania NA, McNeill LH, Oluyomi AO, Fiesinger EB, Minard CG, Solomon A, Hamilton WJ, Patient/Stakeholder Advisory Board and other members of the HIITBAC Research Team:, Butler B, Caldwell J, Crosby E, Davis C, Galvan H, Harris R, Lacour-Chestnut F, Martin C, Pannell S, Phipps K, Richardson G, Solomon A, White W, Boles J, Rangel A, Virk R, Brock M, Guffey D, Ramamurthy U, Persse D, Maffei S, Chan W, Reyes BContemporary clinical trialsDesign of a home-based intervention for Houston-area African-American adults with asthma: Methods and lessons learned from a pragmatic randomized trial. Contemp Clin Trials. 2020 04; 91:105977.Contemp Clin Trials2020-03-06T00:00:002020Design of a home-based intervention for Houston-area African-American adults with asthma: Methods and lessons learned from a pragmatic randomized trial.32154939Agache I, Song Y, Rocha C, Beltran J, Posso M, Steiner C, Alonso-Coello P, Akdis C, Akdis M, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hamelmann E, Hanania N, M?kel? M, Mart?n IH, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, P?rez de Llano L, Quirce S, Sastre J, Shamji M, Schwarze J, Canelo-Aybar C, Palomares O, Jutel MAllergyEfficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma. Allergy. 2020 05; 75(5):1058-1068.Allergy2020-04-01T00:00:002020Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma.Authorship 980174332199709Walther CP, Nambi V, Hanania NA, Navaneethan SDAmerican journal of kidney diseases : the official journal of the National Kidney FoundationDiagnosis and Management of Pulmonary Hypertension in Patients With CKD. Am J Kidney Dis. 2020 06; 75(6):935-945.Am J Kidney Dis2020-03-19T00:00:002020Diagnosis and Management of Pulmonary Hypertension in Patients With CKD.Authorship 987662932304841Buhl R, Korn S, Menzies-Gow A, Aubier M, Chapman KR, Canonica GW, Picado C, Donica M, Kuhlbusch K, Korom S, Hanania NAThe journal of allergy and clinical immunology. In practiceProspective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma. J Allergy Clin Immunol Pract. 2020 09; 8(8):2630-2639.e6.J Allergy Clin Immunol Pract2020-04-15T00:00:002020Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma.Authorship 988318332347748Humbert M, Bourdin A, Papadopoulos NG, Holgate ST, Hanania NA, Halpin DMG, Chapman KR, Gavornikova M, Price DB, Kaplan A, Heaney LGThe Journal of asthma : official journal of the Association for the Care of AsthmaReducing the hidden burden of severe asthma: recognition and referrals from primary practice. J Asthma. 2021 07; 58(7):849-854.J Asthma2020-05-13T00:00:002020Reducing the hidden burden of severe asthma: recognition and referrals from primary practice.Authorship 988625132363206Hanania NA, Papi A, Anzueto A, Martinez FJ, Rossman KA, Cappelletti CS, Duncan EA, Nyberg JS, Dorinsky PMERJ open researchEfficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD. ERJ Open Res. 2020 Apr; 6(2).ERJ Open Res2020-04-27T00:00:002020Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD.Authorship 9897071132426090Morais-Almeida M, Aguiar R, Martin B, Ansotegui IJ, Ebisawa M, Arruda LK, Caminati M, Canonica GW, Carr T, Chupp G, Corren J, D?vila I, Park HS, Hanania NA, Rosenwasser L, S?nchez-Borges M, Virchow JC, Y??ez A, Bernstein JA, Caraballo L, Chang YS, Chikhladze M, Fiocchi A, Gonz?lez-Diaz SN, Tanno LK, Levin M, Ortega-Martell JA, Passalacqua G, Peden DB, Rouadi PW, Sublett JL, Wong GWK, Bleecker ERThe World Allergy Organization journalCOVID-19, asthma, and biological therapies: What we need to know. World Allergy Organ J. 2020 May; 13(5):100126.World Allergy Organ J2020-05-16T00:00:002020COVID-19, asthma, and biological therapies: What we need to know.Authorship 9907404Authorship 9908701532474156Busse WW, Maspero JF, Lu Y, Corren J, Hanania NA, Chipps BE, Katelaris CH, FitzGerald JM, Quirce S, Ford LB, Rice MS, Kamat S, Khan AH, Jagerschmidt A, Harel S, Rowe P, Pirozzi G, Amin N, Ruddy M, Graham NMH, Teper AAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & ImmunologyEfficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2020 11; 125(5):565-576.e1.Ann Allergy Asthma Immunol2020-05-28T00:00:002020Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis.32484954Agache I, Akdis CA, Akdis M, Canonica GW, Casale T, Chivato T, Corren J, Chu DK, Del Giacco S, Eiwegger T, Flood B, Firinu D, Gern JE, Hamelmann E, Hanania N, Hern?ndez-Mart?n I, Knibb R, M?kel? M, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, P?rez de Llano L, Pfaar O, Quirce S, Sastre J, Shamji M, Schwarze J, Palomares O, Jutel MAllergyEAACI Biologicals Guidelines-Recommendations for severe asthma. Allergy. 2021 01; 76(1):14-44.Allergy2020-08-10T00:00:002020EAACI Biologicals Guidelines-Recommendations for severe asthma.Authorship 993726332631932Tervonen T, Hawken N, Hanania NA, Martinez FJ, Heidenreich S, Gilbert IThoraxMaintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment. Thorax. 2020 09; 75(9):735-743.Thorax2020-07-06T00:00:002020Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment.Authorship 994982732693214Bose S, Bime C, Henderson RJ, Blake KV, Castro M, DiMango E, Hanania NA, Holbrook JT, Irvin CG, Kraft M, Peters SP, Reibman J, Sugar EA, Sumino K, Wise RA, Rogers L, American Lung Association Airways Clinical Research CentersThe journal of allergy and clinical immunology. In practiceBiomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST). J Allergy Clin Immunol Pract. 2020 Nov - Dec; 8(10):3474-3481.J Allergy Clin Immunol Pract2020-07-18T00:00:002020Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST).Authorship 1171714Authorship 1172171Authorship 9985821632877963Strand M, Austin E, Moll M, Pratte KA, Regan EA, Hayden LP, Bhatt SP, Boriek AM, Casaburi R, Silverman EK, Fortis S, Ruczinski I, Koegler H, Rossiter HB, Occhipinti M, Hanania NA, Gebrekristos HT, Lynch DA, Kunisaki KM, Young KA, Sieren JC, Ragland M, Hokanson JE, Lutz SM, Make BJ, Kinney GL, Cho MH, Pistolesi M, DeMeo DL, Sciurba FC, Comellas AP, Diaz AA, Barjaktarevic I, Bowler RP, Kanner RE, Peters SP, Ortega VE, Dransfield MT, Crapo JDChronic obstructive pulmonary diseases (Miami, Fla.)A Risk Prediction Model for Mortality Among Smokers in the COPDGene? Study. Chronic Obstr Pulm Dis. 2020 Oct; 7(4):346-361.Chronic Obstr Pulm Dis2020-10-01T00:00:002020A Risk Prediction Model for Mortality Among Smokers in the COPDGene? Study.true1Assistant ProfessorAssistant ProfessorTIANSHI DAVIDWUTIANSHI DAVID WU16241WU, TIANSHI DAVIDAssistant ProfessorAuthorship 999429732918892Lee LA, Bailes Z, Barnes N, Boulet LP, Edwards D, Fowler A, Hanania NA, Kerstjens HAM, Kerwin E, Nathan R, Oppenheimer J, Papi A, Pascoe S, Brusselle G, Peachey G, Sule N, Tabberer M, Pavord IDThe Lancet. Respiratory medicineEfficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. Lancet Respir Med. 2021 01; 9(1):69-84.Lancet Respir Med2020-09-09T00:00:002020Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.http://bcm.edu/asthmaAirways Clinical Research CenterAuthorship 10022442Authorship 1002293133027187Kao CC, Hanania NA, Parulekar ADCurrent opinion in pulmonary medicineThe impact of fungal allergic sensitization on asthma. Curr Opin Pulm Med. 2021 01; 27(1):3-8.Curr Opin Pulm Med2021-01-01T00:00:002021The impact of fungal allergic sensitization on asthma.33031829Hanania NA, Mannino DM, Criner GJ, Dransfield MT, Han MK, Jones CE, Kilbride S, Lomas DA, Martin N, Martinez FJ, Singh D, Wise RA, Halpin DMG, Lima R, Lipson DAChestEffect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial. Chest. 2021 03; 159(3):985-995.Chest2020-10-05T00:00:002020Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial.Authorship 1122381Authorship 100282815Authorship 1002917433054443Yohannes AM, N Eakin M, Holbrook JT, Sugar EA, Henderson R, Baker AM, Casper AS, Kaminsky DA, Rea AL, Mathews AM, Que LG, Ramsdell JW, Gerald LB, Wise RA, Hanania NAExpert review of respiratory medicineAssociation of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study. Expert Rev Respir Med. 2021 01; 15(1):153-159.Expert Rev Respir Med2020-11-18T00:00:002020Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study.33065601Assaf SM, Tarasevych SP, Diamant Z, Hanania NACurrent opinion in pulmonary medicineAsthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps. Curr Opin Pulm Med. 2021 01; 27(1):45-53.Curr Opin Pulm Med2021-01-01T00:00:002021Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps.Authorship 1003528233105236Diamant Z, Hanania NACurrent opinion in pulmonary medicineEditorial: Dealing with asthma during the turbulent times of coronavirus disease-2019. Curr Opin Pulm Med. 2021 01; 27(1):1-2.Curr Opin Pulm Med2021-01-01T00:00:002021Editorial: Dealing with asthma during the turbulent times of coronavirus disease-2019.Authorship 10046132133156982Bourdin A, Criner G, Devouassoux G, Dransfield M, Halpin DMG, Han MK, Jones CE, Kalhan R, Lange P, Lettis S, Lipson DA, Lomas DA, Echave-Sustaeta Mar?a-Tom? JM, Martin N, Martinez FJ, Quasny H, Sail L, Siler TM, Singh D, Thomashow B, Watz H, Wise R, Hanania NAChronic obstructive pulmonary diseases (Miami, Fla.)InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions. Chronic Obstr Pulm Dis. 2021 Jan; 8(1).Chronic Obstr Pulm Dis2021-01-01T00:00:002021InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions.Authorship 10080893Authorship 1008350633387985Tervonen T, Martinez FJ, Hanania NA, Heidenreich S, Eudicone JM, Gilbert IRespiratory medicineDual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment. Respir Med. 2021 01; 176:106278.Respir Med2020-11-29T00:00:002020Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.33408487Quirce S, Heffler E, Nenasheva N, Demoly P, Menzies-Gow A, Moreira-Jorge A, Nissen F, Hanania NAJournal of asthma and allergyRevisiting Late-Onset Asthma: Clinical Characteristics and Association with Allergy. J Asthma Allergy. 2020; 13:743-752.J Asthma Allergy2020-12-31T00:00:002020Revisiting Late-Onset Asthma: Clinical Characteristics and Association with Allergy.Authorship 1009378433098829Yohannes AM, Dryden S, Casaburi R, Hanania NAChestLong-Term Benefits of Pulmonary Rehabilitation in Patients With COPD: A 2-Year Follow-Up Study. Chest. 2021 03; 159(3):967-974.Chest2020-10-22T00:00:002020Long-Term Benefits of Pulmonary Rehabilitation in Patients With COPD: A 2-Year Follow-Up Study.Authorship 1154241Authorship 1013472233685606Pepper AN, Hanania NA, Humbert M, Casale TBThe journal of allergy and clinical immunology. In practiceHow to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit. J Allergy Clin Immunol Pract. 2021 03; 9(3):1081-1088.J Allergy Clin Immunol Pract2021-03-01T00:00:002021How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit.Authorship 1015265133833507Hanania NA, Yohannes AM, Ozol-Godfrey A, Tocco M, Goodin T, Sharma S, Sanjar SInternational journal of chronic obstructive pulmonary diseaseImprovement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies. Int J Chron Obstruct Pulmon Dis. 2021; 16:865-875.Int J Chron Obstruct Pulmon Dis2021-03-31T00:00:002021Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies.33839084Wu TD, Fawzy A, Brigham E, McCormack MC, Rosas I, Villareal DT, Hanania NAChestAssociation of Triglyceride-Glucose Index and Lung Health: A Population-Based Study. Chest. 2021 09; 160(3):1026-1034.Chest2021-04-08T00:00:002021Association of Triglyceride-Glucose Index and Lung Health: A Population-Based Study.Authorship 10161077Authorship 10189371034011367Ebrahimpour A, Wang M, Li L, Jegga AG, Bonnen MD, Eissa NT, Raghu G, Jyothula S, Kheradmand F, Hanania NA, Rosas IO, Ghebre YTJournal of inflammation (London, England)Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway. J Inflamm (Lond). 2021 May 19; 18(1):17.J Inflamm (Lond)2021-05-19T00:00:002021Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway.Authorship 1024220134194225Hanania NA, Caveney S, Soule T, Tombs L, Lettis S, Crim C, Mannino DM, Patel H, Boucot IHInternational journal of chronic obstructive pulmonary diseaseEffect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials. Int J Chron Obstruct Pulmon Dis. 2021; 16:1925-1938.Int J Chron Obstruct Pulmon Dis2021-06-24T00:00:002021Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials.MUHAMMADADRISHMUHAMMAD ADRISH16967ADRISH, MUHAMMAD0000-0002-5553-6182Associate ProfessorAuthorship 10271581134343034Iyer AS, Parekh TM, O'Toole J, Bhatt SP, Eakin MN, Krishnan JA, Yohannes AM, Woodruff PG, Cooper CB, Kanner RE, Hanania NA, Dransfield MT, Regan EA, Hoth KF, Kim V, COPDGene and SPIROMICS InvestigatorsAnnals of the American Thoracic SocietyClinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A Post Hoc Analysis of the COPDGene and SPIROMICS Cohorts. Ann Am Thorac Soc. 2022 01; 19(1):143-146.Ann Am Thorac Soc2022-01-01T00:00:002022Clinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A Post Hoc Analysis of the COPDGene and SPIROMICS Cohorts.Authorship 1028179134419680Hanania NA, Fortis S, Haselkorn T, Gupta S, Mumneh N, Yoo B, Holweg CTJ, Chipps BEThe journal of allergy and clinical immunology. In practiceOmalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRA. J Allergy Clin Immunol Pract. 2022 01; 10(1):222-228.J Allergy Clin Immunol Pract2021-08-19T00:00:002021Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRA.Authorship 1162041Authorship 1029602734511896Strollo HC, Nouraie SM, Hoth KF, Riley CM, Karoleski C, Zhang Y, Hanania NA, Bowler RP, Bon J, Sciurba FCInternational journal of chronic obstructive pulmonary diseaseAssociation of Systemic Inflammation with Depressive Symptoms in Individuals with COPD. Int J Chron Obstruct Pulmon Dis. 2021; 16:2515-2522.Int J Chron Obstruct Pulmon Dis2021-09-03T00:00:002021Association of Systemic Inflammation with Depressive Symptoms in Individuals with COPD.Authorship 1030114634543667Mohan A, Ludwig A, Brehm C, Lugogo NL, Sumino K, Hanania NAChestRevisiting Mild Asthma: Current Knowledge and Future Needs. Chest. 2022 01; 161(1):26-39.Chest2021-09-17T00:00:002021Revisiting Mild Asthma: Current Knowledge and Future Needs.Authorship 1164867Authorship 10310537Authorship 1031085434609549Rosas IO, Diaz G, Gottlieb RL, Lobo SM, Robinson P, Hunter BD, Cavalcante AW, Overcash JS, Hanania NA, Skarbnik A, Garcia-Diaz J, Gordeev I, Carratal? J, Gordon O, Graham E, Lewin-Koh N, Tsai L, Tuckwell K, Cao H, Brainard D, Olsson JKIntensive care medicineTocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Med. 2021 11; 47(11):1258-1270.Intensive Care Med2021-10-05T00:00:002021Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial.34611397Ari A, Blain K, Soubra S, Hanania NAInternational journal of chronic obstructive pulmonary diseaseTreating COPD Patients with Inhaled Medications in the Era of COVID-19 and Beyond: Options and Rationales for Patients at Home. Int J Chron Obstruct Pulmon Dis. 2021; 16:2687-2695.Int J Chron Obstruct Pulmon Dis2021-09-28T00:00:002021Treating COPD Patients with Inhaled Medications in the Era of COVID-19 and Beyond: Options and Rationales for Patients at Home.Authorship 1032335434693967Razjouyan J, Helmer DA, Lynch KE, Hanania NA, Klotman PE, Sharafkhaneh A, Amos CINicotine & tobacco research : official journal of the Society for Research on Nicotine and TobaccoSmoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans. Nicotine Tob Res. 2022 03 26; 24(5):785-793.Nicotine Tob Res2022-03-26T00:00:002022Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans.Authorship 1035606434913814Amin AN, Cornelison S, Woods JA, Hanania NAPostgraduate medicineManaging hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team. Postgrad Med. 2022 Mar; 134(2):152-159.Postgrad Med2021-12-27T00:00:002021Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team.FRANCESCAPOLVERINOFRANCESCA POLVERINO17344POLVERINO, FRANCESCAAssociate ProfessorAuthorship 1036176234958982Pavord ID, Hanania NA, Corren JThe journal of allergy and clinical immunology. In practiceControversies in Allergy: Choosing a Biologic for Patients with Severe Asthma. J Allergy Clin Immunol Pract. 2022 02; 10(2):410-419.J Allergy Clin Immunol Pract2021-12-24T00:00:002021Controversies in Allergy: Choosing a Biologic for Patients with Severe Asthma.Authorship 1190941Authorship 10390854Authorship 10402314Authorship 10410573Authorship 10411623Authorship 1041503435218742Garner O, Ramey JS, Hanania NAChestManagement of Life-Threatening Asthma: Severe Asthma Series. Chest. 2022 Oct; 162(4):747-756.Chest2022-02-23T00:00:002022Management of Life-Threatening Asthma: Severe Asthma Series.35091205Yohannes AM, Casaburi R, Dryden S, Hanania NARespiratory medicinePredictors of premature discontinuation and prevalence of dropouts from a pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respir Med. 2022 03; 193:106742.Respir Med2022-01-20T00:00:002022Predictors of premature discontinuation and prevalence of dropouts from a pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease.35206914Park C, Razjouyan J, Hanania NA, Helmer DA, Naik AD, Lynch KE, Amos CI, Sharafkhaneh AHealthcare (Basel, Switzerland)Elevated Risk of Chronic Respiratory Conditions within 60 Days of COVID-19 Hospitalization in Veterans. Healthcare (Basel). 2022 Feb 04; 10(2).Healthcare (Basel)2022-02-04T00:00:002022Elevated Risk of Chronic Respiratory Conditions within 60 Days of COVID-19 Hospitalization in Veterans.35248549Moss MH, Lugogo NL, Castro M, Hanania NA, Ludwig-Sengpiel A, Saralaya D, Dobek R, Ojanguren I, Vyshnyvetskyy I, Bruey JM, Osterhout R, Tompkins CA, Dittrich K, Raghupathi K, Ortega H, LEDA InvestigatorsChestResults of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma. Chest. 2022 08; 162(2):297-308.Chest2022-03-03T00:00:002022Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma.35052554Kumar P, Osahon O, Vides DB, Hanania N, Minard CG, Sekhar RVAntioxidants (Basel, Switzerland)Severe Glutathione Deficiency, Oxidative Stress and Oxidant Damage in Adults Hospitalized with COVID-19: Implications for GlyNAC (Glycine and N-Acetylcysteine) Supplementation. Antioxidants (Basel). 2021 Dec 27; 11(1).Antioxidants (Basel)2021-12-27T00:00:002021Severe Glutathione Deficiency, Oxidative Stress and Oxidant Damage in Adults Hospitalized with COVID-19: Implications for GlyNAC (Glycine and N-Acetylcysteine) Supplementation.Authorship 10436342Authorship 1043986435427843Yohannes AM, Casaburi R, Dryden S, Hanania NARespiratory medicineThe effectiveness of pulmonary rehabilitation on chronic obstructive pulmonary disease patients with concurrent presence of comorbid depression and anxiety. Respir Med. 2022 06; 197:106850.Respir Med2022-04-09T00:00:002022The effectiveness of pulmonary rehabilitation on chronic obstructive pulmonary disease patients with concurrent presence of comorbid depression and anxiety.35398549Domingo C, Maspero JF, Castro M, Hanania NA, Ford LB, Halpin DMG, Jackson DJ, Daizadeh N, Djandji M, Mitchell CP, Crikelair N, Jacob-Nara JA, Deniz Y, Rowe PJ, Ortiz BThe journal of allergy and clinical immunology. In practiceDupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose. J Allergy Clin Immunol Pract. 2022 07; 10(7):1835-1843.J Allergy Clin Immunol Pract2022-04-08T00:00:002022Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose.Authorship 13690119Authorship 137484323998657Wechsler ME, Laviolette M, Rubin AS, Fiterman J, Lapa e Silva JR, Shah PL, Fiss E, Olivenstein R, Thomson NC, Niven RM, Pavord ID, Simoff M, Hales JB, McEvoy C, Slebos DJ, Holmes M, Phillips MJ, Erzurum SC, Hanania NA, Sumino K, Kraft M, Cox G, Sterman DH, Hogarth K, Kline JN, Mansur AH, Louie BE, Leeds WM, Barbers RG, Austin JH, Shargill NS, Quiring J, Armstrong B, Castro M, Asthma Intervention Research 2 Trial Study GroupThe Journal of allergy and clinical immunologyBronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol. 2013 Dec; 132(6):1295-302.J Allergy Clin Immunol2013-08-30T00:00:002013Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma.24247042Parulekar AD, Atik MA, Hanania NACurrent opinion in pulmonary medicinePeriostin, a novel biomarker of TH2-driven asthma. Curr Opin Pulm Med. 2014 Jan; 20(1):60-5.Curr Opin Pulm Med2014-01-01T00:00:002014Periostin, a novel biomarker of TH2-driven asthma.Authorship 1046053335576775Yohannes AM, Murri MB, Hanania NA, Regan EA, Iyer A, Bhatt SP, Kim V, Kinney GL, Wise RA, Eakin MN, Hoth KF, COPDGene InvestigatorsRespiratory medicineDepressive and anxiety symptoms in patients with COPD: A network analysis. Respir Med. 2022 07; 198:106865.Respir Med2022-05-07T00:00:002022Depressive and anxiety symptoms in patients with COPD: A network analysis.Authorship 1049891135789920Hanania NA, Maspero JF, Halpin DMG, Jackson DJ, Panettieri RA, Castro M, Domingo C, Daizadeh N, Gall R, Jacob-Nara JA, Ortiz B, Djandji M, Rowe PJ, Deniz YJournal of asthma and allergyImprovement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation. J Asthma Allergy. 2022; 15:851-854.J Asthma Allergy2022-06-28T00:00:002022Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation.Authorship 1050283535837794Wallick C, To TM, Korom S, Masters H, Hanania NA, Moawad DJournal of medical economicsImpact of influenza infection on the short- and long-term health of patients with chronic obstructive pulmonary disease. J Med Econ. 2022 Jan-Dec; 25(1):930-939.J Med Econ2022-01-01T00:00:002022Impact of influenza infection on the short- and long-term health of patients with chronic obstructive pulmonary disease.true1ProfessorProfessorBaylor College of Medicine2022Master Clinician Award35965051Adrish M, Anand MP, Hanania NAImmunology and allergy clinics of North AmericaPhenotypes of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunol Allergy Clin North Am. 2022 08; 42(3):645-655.Immunol Allergy Clin North Am2022-06-30T00:00:002022Phenotypes of Asthma-Chronic Obstructive Pulmonary Disease Overlap.36161677Adrish M, Hanania NARespirology (Carlton, Vic.)Choosing and switching biological agents in severe asthma. Respirology. 2022 11; 27(11):926-928.Respirology2022-09-26T00:00:002022Choosing and switching biological agents in severe asthma.Authorship 166816true1Associate ProfessorAssociate ProfessorAuthorship 105849613Authorship 10609662Authorship 10584293Authorship 10573001Authorship 10551681Authorship 106233613Authorship 10623496Authorship 10586641Authorship 105496843Authorship 10572992Authorship 10573011Authorship 10622185Authorship 1058428236628661Garner O, Hanania NAChestIs Extracorporeal Membrane Oxygenation More Than Just Salvage Therapy in Acute Life-Threatening Asthma? Chest. 2023 01; 163(1):1-2.Chest2023-01-01T00:00:002023Is Extracorporeal Membrane Oxygenation More Than Just Salvage Therapy in Acute Life-Threatening Asthma?36254180Hanania NA, Niven R, Chanez P, Antoine D, Pfister P, Garcia Conde L, Jaumont XThe World Allergy Organization journalLong-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma. World Allergy Organ J. 2022 Oct; 15(10):100695.World Allergy Organ J2022-09-25T00:00:002022Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma.36327164Miller MJ, Cash-Goldwasser S, Marx GE, Schrodt CA, Kimball A, Padgett K, Noe RS, McCormick DW, Wong JM, Labuda SM, Borah BF, Zulu I, Asif A, Kaur G, McNicholl JM, Kourtis A, Tadros A, Reagan-Steiner S, Ritter JM, Yu Y, Yu P, Clinton R, Parker C, Click ES, Salzer JS, McCollum AM, Petersen B, Minhaj FS, Brown E, Fischer MP, Atmar RL, DiNardo AR, Xu Y, Brown C, Goodman JC, Holloman A, Gallardo J, Siatecka H, Huffman G, Powell J, Alapat P, Sarkar P, Hanania NA, Bruck O, Brass SD, Mehta A, Dretler AW, Feldpausch A, Pavlick J, Spencer H, Ghinai I, Black SR, Hernandez-Guarin LN, Won SY, Shankaran S, Simms AT, Alarc?n J, O'Shea JG, Brooks JT, McQuiston J, Honein MA, O'Connor SM, Chatham-Stephens K, O'Laughlin K, Rao AK, Raizes E, Gold JAW, Morris SB, CDC Severe Monkeypox Investigations TeamMMWR. Morbidity and mortality weekly reportSevere Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 04; 71(44):1412-1417.MMWR Morb Mortal Wkly Rep2022-11-04T00:00:002022Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022.36332763Hanania NA, Castro M, Bateman E, Pavord ID, Papi A, FitzGerald JM, Maspero JF, Katelaris CH, Singh D, Daizadeh N, Altincatal A, Pandit-Abid N, Soler X, Siddiqui S, Laws E, Jacob-Nara JA, Rowe PJ, Lederer DJ, Hardin M, Deniz YAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & ImmunologyEfficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction. Ann Allergy Asthma Immunol. 2023 02; 130(2):206-214.e2.Ann Allergy Asthma Immunol2022-11-02T00:00:002022Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction.36167120Adviento BA, Regan EA, Make BJ, Han MK, Foreman MG, Iyer AS, Bhatt SP, Kim V, Bon J, Soler X, Kinney GL, Hanania NA, Lowe KE, Holm KE, Yohannes AM, Shinozaki G, Hoth KF, Fiedorowicz JG, COPDGene InvestigatorsChestClinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals With?Smoking Exposure: A Longitudinal Follow-up Study of the COPDGene Cohort. Chest. 2023 02; 163(2):292-302.Chest2022-09-24T00:00:002022Clinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals With?Smoking Exposure: A Longitudinal Follow-up Study of the COPDGene Cohort.36572184Brusselle G, Quirce S, Papi A, Kuna P, Chipps BE, Hanania NA, Blaiss M, Msihid J, Jacob-Nara JA, Deniz Y, Rowe PJ, Gall R, Ortiz B, Djandji M, Radwan AThe journal of allergy and clinical immunology. In practiceDupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic Asthma. J Allergy Clin Immunol Pract. 2023 03; 11(3):873-884.e11.J Allergy Clin Immunol Pract2022-12-23T00:00:002022Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic Asthma.35965040Boulet LP, Hanania NAImmunology and allergy clinics of North AmericaWhen Asthma and Chronic Obstructive Pulmonary Disease Overlap; Current Knowledge and Unmet Needs. Immunol Allergy Clin North Am. 2022 08; 42(3):499-505.Immunol Allergy Clin North Am2022-08-01T00:00:002022When Asthma and Chronic Obstructive Pulmonary Disease Overlap; Current Knowledge and Unmet Needs.36470149Bardsley S, Criner GJ, Halpin DMG, Han MK, Hanania NA, Hill D, Lange P, Lipson DA, Martinez FJ, Midwinter D, Siler TM, Singh D, Wise RA, van Zyl-Smit RN, Berkman NRespiratory medicineSingle-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis. Respir Med. 2022 12; 205:107040.Respir Med2022-11-11T00:00:002022Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.36610384Agusti A, Ambrosino N, Blackstock F, Bourbeau J, Casaburi R, Celli B, Crouch R, Negro RD, Dreher M, Garvey C, Gerardi D, Goldstein R, Hanania N, Holland AE, Kaur A, Lareau S, Lindenauer PK, Mannino D, Make B, Maltais F, Marciniuk JD, Meek P, Morgan M, Pepin JL, Reardon JZ, Rochester C, Singh S, Spruit MA, Steiner MC, Troosters T, Vitacca M, Clini E, Jardim J, Nici L, Raskin J, ZuWallack RRespiratory medicineCOPD: Providing the right treatment for the right patient at the right time. Respir Med. 2023 02; 207:107041.Respir Med2022-12-10T00:00:002022COPD: Providing the right treatment for the right patient at the right time.35965052Hanania NA, Miravitlles MImmunology and allergy clinics of North AmericaPharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunol Allergy Clin North Am. 2022 08; 42(3):657-669.Immunol Allergy Clin North Am2022-08-01T00:00:002022Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap.35965055Hanania NA, Boulet LPImmunology and allergy clinics of North AmericaAsthma-Chronic Obstructive Pulmonary Disease: An Update. Immunol Allergy Clin North Am. 2022 08; 42(3):xiii-xiv.Immunol Allergy Clin North Am2022-06-30T00:00:002022Asthma-Chronic Obstructive Pulmonary Disease: An Update.Authorship 10633228Authorship 1063185836737119Mintz M, Barjaktarevic I, Mahler DA, Make B, Skolnik N, Yawn B, Zeyzus-Johns B, Hanania NAMayo Clinic proceedingsReducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review. Mayo Clin Proc. 2023 02; 98(2):301-315.Mayo Clin Proc2023-02-01T00:00:002023Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review.36717002Tran TV, Kinney GL, Comellas A, Hoth KF, Baldomero AK, Mamary AJ, Curtis JL, Hanania N, Casaburi R, Young KA, Kim V, Make B, Wan ES, Diaz AA, Hokanson J, Crapo JD, Silverman EK, Bhatt SP, Regan E, Fortis S, COPDGene? Investigators ? Core Units, COPDGene? Investigators ? Clinical CentersRespiratory medicinePrevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease. Respir Med. 2023 03; 208:107126.Respir Med2023-01-28T00:00:002023Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease.Authorship 10637602Authorship 1063633436739655Cazzola M, Hanania NA, Rogliani P, Matera MGKardiologia polskaCardiovascular disease in asthma patients: From mechanisms to therapeutic implications. Kardiol Pol. 2023; 81(3):232-241.Kardiol Pol2023-02-05T00:00:002023Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications.36750439Adrish M, Hanania NARespirology (Carlton, Vic.)Asthma and cardiovascular disease: A bidirectional association? Respirology. 2023 03; 28(3):217-219.Respirology2023-02-07T00:00:002023Asthma and cardiovascular disease: A bidirectional association?Authorship 1067533136998390Hanania NA, Bunner SH, Bengtson LGS, Ismaila AS, Bogart MInternational journal of chronic obstructive pulmonary diseaseCOPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. Int J Chron Obstruct Pulmon Dis. 2023; 18:407-418.Int J Chron Obstruct Pulmon Dis2023-03-24T00:00:002023COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA.Authorship 10686044Authorship 10682793037026112Maspero JF, Bachert C, Martinez FJ, Hanania NA, Ortiz B, Patel N, Mannent LP, Praestgaard A, Pandit-Abid N, Siddiqui S, Hardin MJournal of asthma and allergyClinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies. J Asthma Allergy. 2023; 16:333-342.J Asthma Allergy2023-03-31T00:00:002023Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies.37072532Regan EA, Lowe ME, Make BJ, Curtis JL, Chen QG, Cho MH, Crooks JL, Lowe KE, Wilson C, O'Brien JK, Oates GR, Baldomero AK, Kinney GL, Young KA, Diaz AA, Bhatt SP, McCormack MC, Hansel NN, Kim V, Richmond NE, Westney GE, Foreman MG, Conrad DJ, DeMeo DL, Hoth KF, Amaza H, Balasubramanian A, Kallet J, Watts S, Hanania NA, Hokanson J, Beaty TH, Crapo JD, Silverman EK, Casaburi R, Wise RJournal of general internal medicineUse of the Spirometric "Fixed-Ratio" Underdiagnoses COPD in African-Americans in a Longitudinal Cohort Study. J Gen Intern Med. 2023 10; 38(13):2988-2997.J Gen Intern Med2023-04-18T00:00:002023Use of the Spirometric "Fixed-Ratio" Underdiagnoses COPD in African-Americans in a Longitudinal Cohort Study.Authorship 1221602Authorship 10697055Authorship 1069398637199256Striz I, Golebski K, Strizova Z, Loukides S, Bakakos P, Hanania NA, Jesenak M, Diamant ZClinical science (London, England : 1979)New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. Clin Sci (Lond). 2023 05 18; 137(9):727-753.Clin Sci (Lond)2023-05-18T00:00:002023New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.37189529Murugesan N, Saxena D, Dileep A, Adrish M, Hanania NADiagnostics (Basel, Switzerland)Update on the Role of FeNO in Asthma Management. Diagnostics (Basel). 2023 Apr 15; 13(8).Diagnostics (Basel)2023-04-15T00:00:002023Update on the Role of FeNO in Asthma Management.Authorship 10727473Authorship 10723968Authorship 10722846Authorship 10742573Authorship 10721042Authorship 10722713Authorship 1074094237408603Cazzola M, Hanania NA, Page CP, Matera MGInternational journal of chronic obstructive pulmonary diseaseNovel Anti-Inflammatory Approaches to COPD. Int J Chron Obstruct Pulmon Dis. 2023; 18:1333-1352.Int J Chron Obstruct Pulmon Dis2023-06-29T00:00:002023Novel Anti-Inflammatory Approaches to COPD.37260227Mohan A, Lugogo NL, Hanania NA, Reddel HK, Akuthota P, O'Byrne PM, Guilbert T, Papi A, Price D, Jenkins CR, Kraft M, Bacharier LB, Boulet LP, Yawn BP, Pleasants R, Lazarus SC, Beasley R, Gauvreau G, Israel E, Schneider-Futschik EK, Yorgancioglu A, Martinez F, Moore W, Sumino KAmerican journal of respiratory and critical care medicineQuestions in Mild Asthma: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023 06 01; 207(11):e77-e96.Am J Respir Crit Care Med2023-06-01T00:00:002023Questions in Mild Asthma: An Official American Thoracic Society Research Statement.37385337Oppenheimer J, Hanania NA, Chaudhuri R, Sagara H, Bailes Z, Fowler A, Peachey G, Pizzichini E, Slade DChestClinic vs?Home Spirometry for Monitoring Lung Function in Patients With Asthma. Chest. 2023 11; 164(5):1087-1096.Chest2023-06-27T00:00:002023Clinic vs?Home Spirometry for Monitoring Lung Function in Patients With Asthma.37272521Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Mannent LP, Patel N, Staudinger HW, Yancopoulos GD, Mortensen ER, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM, BOREAS InvestigatorsThe New England journal of medicineDupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts. N Engl J Med. 2023 Jul 20; 389(3):205-214.N Engl J Med2023-05-21T00:00:002023Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.37316689Matera MG, Hanania NA, Maniscalco M, Cazzola MDrugs & agingPharmacotherapies in Older Adults with COPD: Challenges and Opportunities. Drugs Aging. 2023 07; 40(7):605-619.Drugs Aging2023-06-14T00:00:002023Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities.37377851Stolz D, Matera MG, Rogliani P, van den Berge M, Papakonstantinou E, Gosens R, Singh D, Hanania N, Cazzola M, Maitland-van der Zee AH, Fregonese L, Mathioudakis AG, Vestbo J, Rukhadze M, Page CPBreathe (Sheffield, England)Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022. Breathe (Sheff). 2023 Jun; 19(2):220267.Breathe (Sheff)2023-06-13T00:00:002023Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022.37236628Cazzola M, Rogliani P, Barnes PJ, Blasi F, Celli B, Hanania NA, Martinez FJ, Miller BE, Miravitlles M, Page CP, Tal-Singer R, Matera MGAmerican journal of respiratory and critical care medicineAn Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials. Am J Respir Crit Care Med. 2023 08 15; 208(4):374-394.Am J Respir Crit Care Med2023-08-15T00:00:002023An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials.Authorship 10748542Authorship 1075095437474159Cazzola M, Page CP, Matera MG, Rogliani P, Hanania NAThe European respiratory journalRevisiting asthma pharmacotherapy: where do we stand and where do we want to go? Eur Respir J. 2023 08; 62(2).Eur Respir J2023-08-17T00:00:002023Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?37454981Diamant Z, Seys SF, Rogers L, Hanania NARespiratory medicineIntegrating innovations in asthma research into clinical practice. Respir Med. 2023 10; 217:107345.Respir Med2023-07-14T00:00:002023Integrating innovations in asthma research into clinical practice.Authorship 130851Authorship 10782791Authorship 10780995Authorship 107926412Authorship 10772382Authorship 10780383Authorship 10785682737531185Adrish M, Hanania NAAmerican journal of respiratory and critical care medicineRevisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer? Am J Respir Crit Care Med. 2023 09 01; 208(5):509-511.Am J Respir Crit Care Med2023-09-01T00:00:002023Revisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer?37517623Diamant Z, Jesenak M, Hanania NA, Heaney LG, Djukanovic R, Ryan D, Quirce S, Backer V, Gaga M, Pavord I, Antol?n-Am?rigo D, Assaf S, Bakakos P, Bobcakova A, Busse W, Kappen J, Loukides S, van Maaren M, Panzner P, Pite H, Spanevello A, Stenberg H, Striz I, Thio B, Vasakova MK, Conti D, Fokkens W, Lau S, Scadding GK, Van Staeyen E, Hellings PW, Bjermer LRespiratory medicineEUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients. Respir Med. 2023 11; 218:107361.Respir Med2023-07-28T00:00:002023EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients.37545746Kerr M, Tarabichi Y, Evans A, Mapel D, Pace W, Carter V, Couper A, Drummond MB, Feigler N, Federman A, Gandhi H, Hanania NA, Kaplan A, Kostikas K, Kruszyk M, van Melle M, M?llerov? H, Murray R, Ohar J, Pollack M, Pullen R, Williams D, Wisnivesky J, Han MK, Meldrum C, Price DLancet regional health. AmericasPatterns of care in the management of high-risk COPD in the US (2011-2019): an observational study for the CONQUEST quality improvement program. Lancet Reg Health Am. 2023 Aug; 24:100546.Lancet Reg Health Am2023-07-28T00:00:002023Patterns of care in the management of high-risk COPD in the US (2011-2019): an observational study for the CONQUEST quality improvement program.37611073Regan EA, Lowe ME, Make BJ, Curtis JL, Chen QG, Crooks JL, Wilson C, Oates GR, Gregg RW, Baldomero AK, Bhatt SP, Diaz AA, Benos PV, O'Brien JK, Young KA, Kinney GL, Conrad DJ, Lowe KE, DeMeo DL, Non A, Cho MH, Kallet J, Foreman MG, Westney GE, Hoth K, MacIntyre NR, Hanania NA, Wolfe A, Amaza H, Han M, Beaty TH, Hansel NN, McCormack MC, Balasubramanian A, Crapo JD, Silverman EK, Casaburi R, Wise RAAmerican journal of respiratory and critical care medicineEarly Evidence of Chronic Obstructive Pulmonary Disease Obscured by Race-Specific Prediction Equations. Am J Respir Crit Care Med. 2024 Jan 01; 209(1):59-69.Am J Respir Crit Care Med2024-01-01T00:00:002024Early Evidence of Chronic Obstructive Pulmonary Disease Obscured by Race-Specific Prediction Equations.37567514Assaf S, Stenberg H, Jesenak M, Tarasevych SP, Hanania NA, Diamant ZRespiratory medicineAsthma in the era of COVID-19. Respir Med. 2023 11; 218:107373.Respir Med2023-08-10T00:00:002023Asthma in the era of COVID-19.37683775Hanania NARespiratory medicineGuest Editor's bio: Dr. Nicola A. Hanania. Respir Med. 2023 11; 218:107405.Respir Med2023-09-06T00:00:002023Guest Editor's bio: Dr. Nicola A. Hanania.Authorship 1079775237752621Corren J, Hanania NA, Busse WW, Sher LD, Altincatal A, Hardin M, Mannent LP, Amin N, Lederer DJ, Soler X, Jacob-Nara JA, Rowe PJ, Deniz YClinical and experimental allergy : journal of the British Society for Allergy and Clinical ImmunologyEfficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization. Clin Exp Allergy. 2023 10; 53(10):1020-1030.Clin Exp Allergy2023-09-26T00:00:002023Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization.Authorship 1080345437776915Rogers L, Jesenak M, Bjermer L, Hanania NA, Seys SF, Diamant ZRespiratory medicineBiologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient. Respir Med. 2023 11; 218:107414.Respir Med2023-09-29T00:00:002023Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.Authorship 108281715Authorship 1082542137903807Silverman EK, Kim AY, Make BJ, Regan EA, Morrow JD, Hersh CP, O'Brien J, Crapo JD, Hansel NN, Criner G, Flenaugh EL, Conrad D, Casaburi R, Bowler RP, Hanania NA, Barr RG, Bhatt SP, Sciurba FC, Anzueto A, Han MK, McEvoy CE, Comellas AP, DeMeo DL, Rosiello R, Curtis JL, Uchida T, Wilson C, O'Rourke PPNPJ genomic medicineReturning incidentally discovered Hepatitis C RNA-seq results to COPDGene study participants. NPJ Genom Med. 2023 Oct 31; 8(1):36.NPJ Genom Med2023-10-31T00:00:002023Returning incidentally discovered Hepatitis C RNA-seq results to COPDGene study participants.37919843Hanania NA, Settipane RA, Khoury S, Shaikh A, Dotiwala Z, Casciano J, Foggs MBAllergy and asthma proceedingsAdding tiotropium or long-acting ?2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization. Allergy Asthma Proc. 2023 11 13; 44(6):413-421.Allergy Asthma Proc2023-11-13T00:00:002023Adding tiotropium or long-acting ?2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization.Authorship 139622Authorship 20961Authorship 108517012Authorship 1084991738070771Casale TB, Chipps BE, Iqbal A, Yoo B, Millette LA, Hanania NAThe journal of allergy and clinical immunology. In practiceInfluence of baseline bronchodilator reversibility and blood eosinophils on lung function in patients with asthma following omalizumab. J Allergy Clin Immunol Pract. 2024 02; 12(2):512-514.e2.J Allergy Clin Immunol Pract2023-12-08T00:00:002023Influence of baseline bronchodilator reversibility and blood eosinophils on lung function in patients with asthma following omalizumab.38098649Wallick C, To TM, Korom S, Masters H, Wu N, Moawad D, Hanania NAInfluenza and other respiratory virusesImpact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection. Influenza Other Respir Viruses. 2023 Dec; 17(12):e13231.Influenza Other Respir Viruses2023-12-13T00:00:002023Impact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection.Authorship 1085935438146651Caminati M, Buhl R, Corren J, Hanania NA, Kim H, Korn S, Lommatzsch M, Martin N, Matucci A, Nasser SM, Pavord ID, Domingo CAllergyTezepelumab in patients with allergic and eosinophilic asthma. Allergy. 2023 Dec 26.Allergy2023-12-26T00:00:002023Tezepelumab in patients with allergic and eosinophilic asthma.true1Associate ProfessorAssociate ProfessorAuthorship 1087644838253245Chase NM, Littlejohn M, Holweg CTJ, Millette LA, Seetasith A, Steinke JW, Trzaskoma BL, Hanania NA, Casale TBRespiratory medicineEffectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma. Respir Med. 2024 Mar; 223:107537.Respir Med2024-01-20T00:00:002024Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma.Authorship 1088391438321329Matera MG, Calzetta L, Rogliani P, Hanania N, Cazzola MLungCardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020-2023. Lung. 2024 Feb 06.Lung2024-02-06T00:00:002024Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020-2023.Authorship 10887983Authorship 1088929638360213Corren J, Szefler SJ, Sher E, Korenblat P, Soong W, Hanania NA, Berman G, Brusselle G, Zitnik R, Natalie CR, Sun L, Siu K, Wu WS, Lio P, Armstrong AWThe journal of allergy and clinical immunology. In practiceLebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population. J Allergy Clin Immunol Pract. 2024 Feb 14.J Allergy Clin Immunol Pract2024-02-14T00:00:002024Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population.38365175Wu TD, Diamant Z, Hanania NAChestAn Update on Patient-Reported Outcomes in Asthma. Chest. 2024 Feb 15.Chest2024-02-15T00:00:002024An Update on Patient-Reported Outcomes in Asthma.true1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate ProfessorAuthorship 197092Authorship 238804Authorship 179686Authorship 180013Authorship 193115Authorship 261471Authorship 235881Authorship 24655124644290Koshy S, Huq R, Tanner MR, Atik MA, Porter PC, Khan FS, Pennington MW, Hanania NA, Corry DB, Beeton CThe Journal of biological chemistryBlocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma. J Biol Chem. 2014 May 02; 289(18):12623-32.J Biol Chem2014-03-18T00:00:002014Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma.Authorship 236801Authorship 368165Authorship 286322Authorship 437512Authorship 322421Authorship 1410941Authorship 142117424120253Hanania NA, Calverley PM, Dransfield MT, Karpel JP, Brose M, Zhu H, Goehring UM, Rowe PRespiratory medicinePooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD. Respir Med. 2014 Feb; 108(2):366-75.Respir Med2013-09-30T00:00:002013Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD.24429127Dransfield MT, Bourbeau J, Jones PW, Hanania NA, Mahler DA, Vestbo J, Wachtel A, Martinez FJ, Barnhart F, Sanford L, Lettis S, Crim C, Calverley PMThe Lancet. Respiratory medicineOnce-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials. Lancet Respir Med. 2013 May; 1(3):210-23.Lancet Respir Med2013-04-12T00:00:002013Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.Authorship 32044Authorship 471571Authorship 490562Authorship 1436038Authorship 534871Authorship 584801Authorship 146921124791167Hanania NAAnnals of thoracic medicineThe Saudi guidelines for chronic obstructive pulmonary disease: A fresh "Real-World" approach to COPD. Ann Thorac Med. 2014 Apr; 9(2):53-4.Ann Thorac Med2014-04-01T00:00:002014The Saudi guidelines for chronic obstructive pulmonary disease: A fresh "Real-World" approach to COPD.Authorship 433985Authorship 424451Authorship 456431Authorship 4622010Authorship 627162Authorship 467111Authorship 630732Authorship 465441Authorship 486121Authorship 668851Authorship 494251Authorship 711312Authorship 733673Authorship 734906Authorship 757611Authorship 758814Authorship 581451Authorship 829903Authorship 833971Authorship 604823Authorship 1514594Authorship 1516003Authorship 151637225130680Sharafkhaneh A, Altan AE, Colice GL, Hanania NA, Donohue JF, Kurlander JL, Rodriguez-Roisin R, Altman PRRespiratory medicineA simple rule to identify patients with chronic obstructive pulmonary disease who may need treatment reevaluation. Respir Med. 2014 Sep; 108(9):1310-20.Respir Med2014-07-14T00:00:002014A simple rule to identify patients with chronic obstructive pulmonary disease who may need treatment reevaluation.25177479Qureshi H, Sharafkhaneh A, Hanania NATherapeutic advances in chronic diseaseChronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Ther Adv Chronic Dis. 2014 Sep; 5(5):212-27.Ther Adv Chronic Dis2014-09-01T00:00:002014Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications.25213045Humbert M, Busse W, Hanania NA, Lowe PJ, Canvin J, Erpenbeck VJ, Holgate SThe journal of allergy and clinical immunology. In practiceOmalizumab in asthma: an update on recent developments. J Allergy Clin Immunol Pract. 2014 Sep-Oct; 2(5):525-36.e1.J Allergy Clin Immunol Pract2014-06-11T00:00:002014Omalizumab in asthma: an update on recent developments.Authorship 612671DHARANINARENDRADHARANI NARENDRA7997NARENDRA, DHARANIAssistant ProfessorAuthorship 640662Authorship 645352Authorship 906111Authorship 9110514Authorship 669571Authorship 990573Authorship 705141Authorship 739606Authorship 742901Authorship 759201Authorship 777985Authorship 785172Authorship 770301Authorship 796963Authorship 1548422Authorship 1552852Authorship 1559166